University of San Diego

Digital USD
Dissertations

Theses and Dissertations

2011-05-10

Cord Blood Collection in Pregnant Women for Stem Cell Research
Irene Carr PhD
University of San Diego

Follow this and additional works at: https://digital.sandiego.edu/dissertations
Part of the Nursing Commons

Digital USD Citation
Carr, Irene PhD, "Cord Blood Collection in Pregnant Women for Stem Cell Research" (2011). Dissertations.
401.
https://digital.sandiego.edu/dissertations/401

This Dissertation: Open Access is brought to you for free and open access by the Theses and Dissertations at
Digital USD. It has been accepted for inclusion in Dissertations by an authorized administrator of Digital USD. For
more information, please contact digital@sandiego.edu.

UNIVERSITY OF SAN DIEGO
Hahn School of Nursing and Health Science
DOCTOR OF PHILOSPHY IN NURSING

CORD BLOOD COLLECTION IN PREGNANT WOMEN
FOR STEM CELL RESEARCH
by
Irene Carr

A dissertation presented to the
FACULTY OF THE HAHN SCHOOL OF NURSING AND HEALTH SCIENCE
UNIVERSITY OF SAN DIEGO

In partial fulfillment of the
requirements for the degree
DOCTOR OF PHILOSOPHY IN NURSING
May 10,2011

Dissertation Committee
Jane Georges, Ph.D., R.N., Chair
Patricia Roth, Ed.D., R.N.
Kathy James, Ph.D., R.N.

Abstract
Umbilical cord blood (UCB) stem cells form commonly banked types of human
tissue. Confusion remains about sources of stem cells and their use. Birth is a once in a
lifetime opportunity with 74 million births per year in the world and four million occur in
the United States. Cord blood contains hematopoietic stem cells and pluripotent
mesenchymal cells (Moise, 2005). There is a surge of interest in the clinical use and
research investigation of umbilical cord blood for transplantation and regenerative
medicine. Clinicians need increased awareness and education of options for private
versus public donation and banking of cord blood at birth to present to pregnant patients.
The aims of this research were to describe decision-making readiness and
communication with mothers and their partners during her pregnancy using the
Transtheoretical Model (Prochaska, J.O. and DiClemente, C.C, 1982). Describe the
relationship between age, pregnant women's level of parity, gestational age, highest level
of education, marital status, race, religion, economic status, and plan of payment for
prenatal care to their sources ofknowledge, their beliefs and knowledge regarding cord
blood transplantation. Perceptions of pregnant women's cord blood use and their
understanding of the difference between public and private cord blood storage banks and
use. The partner's perceptions of cord blood use and their understanding of the difference
between public and private cord blood storage banks and use.
The voluntary sample consisted of 30 participants of convenience from two
obstetrical clinics from a local clinic. The design was a quantitative method staging an
algorithm for Cord Blood Donation using a Decision of Readiness Scale along with
notification of significant other. The Cord Blood Survey measured sources of knowledge,

beliefs, and knowledge of cord blood transplantation. The Statistical Package for the
Social Sciences (SPWS 18.0) was used to perform an analysis of data. Descriptive
statistics were used to summarize the demographic variables and to identify central
tendency, variability and percentages of key variables. One-way ANOVA and /-test were
computed on the quantitative questions. Qualitative measures from randomly selected
post interviews of 1/3 of the sample were completed.
The barriers to understanding what umbilical cord blood donation options and
how pregnant women make decisions regarding umbilical cord blood donations are
explored. The implications for nursing research are: overcoming the barriers to
understanding the difference between private and public banking and the ramifications of
each option; add to nursing knowledge by understanding when and how women make
decisions about umbilical cord blood donation; and future studies could investigate
ethical implications of umbilical cord blood donation and best nursing practice guidelines
for approaching pregnant women and their partners on umbilical cord blood donation
options.
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Chapter 1
Introduction
Stem cells from umbilical cord blood form one of the most commonly banked
types of human tissue. Birth is a time when stem cell collection is an option through
umbilical cord blood collection. Despite over 74 million births per year in the world and
of those four million of which occur in the United States (World Watch Institute, 2006,
p.75), many people remain unaware of human umbilical cord blood collection (Cryo-cell,
2006). Who would have known thirty-five years ago, when this researcher a new
graduate nurse routinely collecting cord blood at a birth to determine the baby's blood
type, some day one would be collecting it for stem cell research on a baby. To make the
decision to bank cord blood for stem cell collection is a life experience one can only
capture at a timely moment

Birth!

The debate over embryonic stem cell research continues in the news headlines
over the last two decades. Despite this, many people remain unaware that the human
umbilical cord blood and other noncontroversial stem cell sources, such as the placenta,
are routinely used in medical treatments. Tremendous confusion and lack of
understanding about the different sources of stem cells and their use affects members of
the government, public, and medical community. It is important to note that embryonic
1
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tissue is not the only source of stem cells and is not part of this study (see Appendix A:
Sources of Stem Cells). Until 1988 (Smith & Thomson, 2000) and April, 2006 (Cryocell, 2006), blood that remained in the umbilical cord and placenta, respectfully, after
delivery used to be routinely discarded. Now several studies have confirmed with similar
results this blood is known to contain hematopoietic stem cells and pluripotent
mesenchymal cells (Moise, 2005); undifferentiated cells that can develop into virtually
any type of blood cell in the human body; and provides a better alternative to bone
marrow transplantation to treat an expanding list of malignant, benign, and inherited
disorders (Perlow, 2002) (see Appendix B showing a list of diseases potentially treatable
with stem cells from umbilical cord blood). As a result, a surge of interest in the clinical
use and research investigation of umbilical and placental stem cells in transplantation and
regenerative medicine has evolved in the science of stem cell research.
Background of the Problem
Until President George W. Bush signed a bill December 20,2005, the Federal
Drug Administration (FDA) had no control over some of the standardizations for
collection and processing of cord blood in public banks (Institute of Medicine, 2005 &
2006; Perlow, 2006). The debate regarding private banking of autologous blood for
"biological insurance" versus public banking for access by the general public continues
today. Lack of knowledge and expense remain as barriers to umbilical cord blood
collection and placenta stem cell collection. Opportunities to educate patients and
obstetrical providers in these areas need to be pursued if one is to make a true informed
decision (Perlow, 2002). Obstetrical providers need to support acquisition but many do
not even have a basic understanding of newborn stem cell research derived from post-
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delivery stem cell banking. Patients are poorly informed about options in umbilical blood
banking, especially in ethnic minorities (Perlow, 2006), and unless a parent, relative, or
friend opens the internet specifically to download umbilical cord blood collection or
placental stem cell collection and obtains the information somewhat easily, this process
of collection is virtually unknown to the public. Many people, including medical
professionals, are eager to learn more about newborn stem cell (NBSC) banking, yet they
are unaware of recent regenerative medicine research or the many diseases that are
currently treatable with stem cells. Pregnant women, who not only decide the fate of their
newborn's wardrobe colors, and ultimately the choice to collect stem cells, frequently
look to their clinicians for guidance in evaluating their options to collect stem cells or not
to collect stem cells and how to go about it! In addition, many health care professionals
are unaware of the federal legislation to establish nationwide cord blood banks. They
have never initiated a discussion with a patient about cord blood banking and are
unprepared to answer an expectant mothers' question (Young, 2006). As more pregnant
women become aware of the importance of cord blood stem cells, it is increasingly
necessary for clinicians to be well informed. Considering the accessibility and availability
of large quantities of newborn stem cells (NBSC), it seems likely that much of the future
of stem cell therapy may depend heavily on newborn stem cells.
Originally stored for the treatment of hematological disorders stem cells have now
been found to be more versatile for potential use in the treatment of a broader range of
disorders and diseases and may be particularly valuable in cell therapy and regenerative
medicine (Gunning & Holm, 2006, p. 17; Waldby, 2006). The storage of umbilical cord
cells has not been without controversy and there is rapidly growing private sector

4

involvement. Over the last two decades umbilical cord blood has proved an effective
substitute for bone marrow in the treatment of blood disorders, and most nations in the
developed world have public programs for the harvesting and storage of cord blood for
allogenic transplantation (Garcia & Torrabadella, 2006; Waldby, 2006). Yet, a number of
ethical issues continue to be debated involving questions of regulation and quality
assurance, ownership and commercialization, patenting, and thefinancialconstraints
could make this unreachable for marginalized populations in the United States. The
researcher will first present the historical background of related and unrelated cord blood
to establish the legitimacy of the science, public versus private banking, regulation and
quality assurance of banking and the worldwide influence cord blood banking has on
regenerative medicine.
Purpose of the Study
The study researched and investigated issues surrounding knowledge by
healthcare providers and patients' perceptions of cord blood collection or newborn stem
cell collection (NBSC) and banking. From a philosophical perspective this appears to be
a source of hegemony where the issue is dominated from a white male power base whose
only voice seems to matter in the present situation. However, this researcher would like
to take a postmodernist viewpoint and approach it with a critical/feminist theory where
everyone has a place in the dialogue. Habermas a major contributor to critical theory and
stressed: human beings in dialogue with each other are the foundation for emancipatory
social thought and we all need to have a voice in this through the truths claimed and
communication shared about the issues (Finlayson, 2005, page 59; J.M. Georges personal
communication, September 7 & 14,2006).
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This purpose of the study investigated pregnant women's knowledge of cord
blood collection and what decision-making process they experience to donate cord blood
at their birth. The research question: What characteristics during a woman's
pregnancy are possibly related when making a decision for cord blood donation at
birth?
Specific aims for this inquiry are as follows:
1) To describe the readiness of decision-making and communication to her significant
other during a given time in a pregnant woman's gestational age.
2) To describe pregnant women's age, weeks of pregnancy (gestational age), level of
parity (number of pregnancies), marital status, race, religion, highest level of education,
economic status and method of payment for prenatal care.
3) To examine the relationships between women's age, weeks of pregnancy (gestational
age), level of parity (number of pregnancies), marital status, race, religion, highest level
of education, economic status and method of payment for prenatal care.
4) To examine pregnant women's perceptions of cord blood use, difference between
public and private cord blood storage banks and use.
5) To examine pregnant women's partner's perceptions of cord blood use, difference
between public and private cord blood storage banks and use.
Conceptual Framework
The transtheoretical model (TTM) of change provides an alternative way of
grouping patients according to their stage of readiness to learn and adopt new beliefs and
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by
understanding the clients' readiness to change one can design intervention to increase the
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chance of successful implementation (Haslam & Haslam, 2000). The dimensions
described in the model, the stages, processes, context, and markers of change, are
designed to assist in picturing and understanding the process of change (Prochaska &
DiCIemente, 1984; DiClemente & Prochaska, 1998, pp.3-24; DiClemente, 2003).
Transtheoretical Model (TTM) incorporates elements of various theories of therapy,
learning, and behavior change, hence the term 'Transtheoretical'. The model, however,
does not try to resolve all the conceptual issues and conflicts among the various theories
incorporated in the model. It simple tries to identify and describe important elements of
the process of intentional behavior change (DiClemente, 2007) (see Appendix C for
figure of Stages of Change Model).
Scope and Delimitations of the Study
Umbilical cord cell transplantation has evolved over the last 15 years from being
an experimental procedure to an accepted treatment for a number of hematological
diseases and genetic disorders. Presently it is used, for example, in treatment of Acute
Myelogenous Leukemia, Chronic Myelogenous Leukemia, Acute Lymphoblastic
Leukemia, Chronic Lymphocytic Leukemia, Juvenile Myelomonocytic Leukemia,
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myeloma (cancer of plasma cells)
and Wiskott - Aldrich Syndrome to name a few (see Appendix B). During the evolution
of banking cord blood as human tissue it has increased exponentially around the world.
The proliferation of private cord cell banks has been particularly strong in the USA and
Asia while, in Europe, where there are one or two old established private banks, the
emphasis has been on public cord cell banking (Agarwal, 2006; Greenwood, 2006). But,
whether in the private or public cord cell banking sector, there remains alternate quality
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assurance standards that need addressing. This will become particularly important if cord
blood stem cells are to play an important part in the cellulaf therapies of regenerative
medicine in the future (Greenwood, 2006) (see Appendices D and E). As the utility of
these cells increases countries may have to consider whether cord blood should be
collected from all newborns. This will be a costly process if only obtained by the private
banks and may be the promotion of public cord blood donation but with the
acknowledgement that one has therightto private storage may prove a practical way
forward. It is also clear within this frontier of science that new ethical questions will
continue to arise.
Outline ofProposal
Following this introduction, a review of current relevant literature in the area was
presented. The conceptual model was discussed as how it is related to this study by laying
the framework for the area of inquiry. Operational definitions were reviewed.
Explanation of the dissertation's importance to the advancement of knowledge,
nursing science, and nursing practice were addressed. The methods to be used in this
study were then described, including a detailed description of the research procedure and
proposed data analysis plans.

Chapter II
Overview
Just as the "interests and welfare of the human being prevail over the sole
interests of science and society so does society and the culture of healthcare send us into
new technology", (Gunning & Holm, 2006, p. 7, Chap. 2). This section briefly describes
the milestones reached in umbilical cord blood transplantation. The researcher will first
present the historical background of related and unrelated cord blood to establish the
legitimacy of the science, public versus private banking, then expand on the regulation
and quality assurance of banking and the worldwide influence cord blood banking has on
regenerative medicine.
Historical Background
Stem cell research started in 1925 (Maximow, 1925, pp.47-113) and has been a
very controversial subject when connected to embryonic stem cell research. However,
umbilical cord blood and placental stem cells are not considered embryonic but are
embryonic-like and are now classified currently under newborn stem cell research. The
study of umbilical cord blood began in 1982, when discussions between Broxmeyer and
Boyse led to laboratory experiments suggesting umbilical cord blood contained
hematopoietic stem cells that might be suitable for transplantation (Broxmeyer, 1998, (a);
8

9
Broxmeyer & Smith, 1998, (b).The concept of using umbilical cord blood as a source of
stem cells was first proposed by Edward Boyse in 1983 (Wagner, 1993).
Because of the need for quick access when patients were seeking a match for
transplantation with their blood an organized blood banking system soon seemed to be
the answer. Broxmeyer and Boyses' (Smith & Thomson, 2000) laboratory-based research
led to establishing umbilical cord blood banking and was first successful at Indiana
University to harvest cells from the siblings of children needing transplants. One of these
units was used to perform the first related sibling transplant with umbilical cord blood in
a 6 year-old boy with Fanconi anemia in 1988 in Paris, France (Gluckman et al., 1989).
Gluckman further described this as a trans-Atlantic collaborative effort as the cell
processing was done in the USA and hand carried to the patient in France. It was after
this case that cord blood banks were established in the early 1990's first in New York in
1993 and then in Europe through the London Cord Blood Bank, the first in the UK set up
in 1996 (Waldby, 2005). Subsequently, over 35 cord blood banks have been established
in 21 countries and today there are over 150,000 cord blood units worldwide both in the
public and private sectors (Bone Marrow Donors Worldwide, 2003, Chap. 3; Agarwal,
2006)
One year later in 1989 Harris and colleagues performed the first umbilical cord
blood transplant matched to a related sibling in Cincinnati (Gluckman, 1989; Smith &
Thomson, 2000). Kurtzberg and colleagues at Duke University in Durham, NC,
performed the first successful unrelated sibling umbilical cord blood transplant in the
United States in 1993 (Kurtzberg, Graham, Olson, Stevens, & Rubenstein, 1994). The
possibility to use unrelated donor cord blood grafts stimulated the need for a storage bank
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of unrelated donor cord blood units. To address this need, Rubinstein and colleagues at
the New York Blood Center created the fastpublic umbilical cord blood bank, designed
to test the safety and efficacy of collecting, testing, cryopreserving, and dispersing
umbilical cord blood collected from unrelated donors to transplant centers (Rubinstein,
Rosenfeld, Adamson, & Stevens, 1993; Rubinstein, Taylor & Scaradavou, 1994;
Rubinstein, Carrier, & Scaradavou, 1998).
The first private cord blood bank, Biocyte Corporation, was set up in Connecticut
in 1993 (Holden, 1993) and now private cord blood banks operate throughout the USA,
Europe and Asia. Wagner published the first series of cord blood recipients in 1995
representing the Placental and Umbilical Cord Blood Registry (Wagner, Kernan, &
Steinbach, 1995). They reported the transplant results for 44 related, sibling cord blood
grafts. This was followed in 1996 by Duke University's center reporting 25 unrelated
donor cord blood transplants (Kurtzberg, Laughlin, & Graham, 1996) and in 1997 by
Gluckman's report of the European experience with 78 related and 65 unrelated donor
cord blood transplants (Gluckman, Rocha, & Boyer-Chammard, 1997). In 1998
Rubinstein reported the results of 562 unrelated donor cord blood transplants that were
facilitated by the New York Blood Center's cord blood bank in New York City which is
the largest series of cord blood transplants reported to date (Rubinstein, Rosenfeld,
Adamson, & Stevens, 1993; Rubinstein, Taylor & Scaradavou, 1994; Rubinstein, Carrier,
& Scaradavou, 1998). Recently, April 2006, Cryo-cell and Gen-cell were the first to
initiate the collection of placentas for placental stem cell research (Cryo-cell, 2006). The
reports provide important and encouraging results on cord blood obtainedfromrelated
and unrelated donors establish a basic foundation for the science of stem cell research
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and hope for parents who desire information on this issue. The replication of the science
sets afirmbases on which to set a practice of use worldwide (see Appendix F: Historical
Milestones of Umbilical Cord Blood Banking and Transplantation).
What is Public Banking vs. Private Banking?
> Information regarding umbilical cord blood (UCB) banking is surfacing at an
accelerated rate in the past few years. The messages, with the predominate target towards
vulnerable populations as pregnant women, women of childbearing age and women,
encourage mothers-to-be to bank their child's umbilical cord blood. Because UCB stem
cells must be collected at birth, women should decide what to do with their child's
umbilical cord blood well in advance. To discard, donate for research, publicly store or
privately store UCB stem cells—these are potential choices that have to be made. As
anticipated, a growing number of Internet sites and magazines advertisements are
cautioning women that storing a newborn's UCB is a once-in-a-lifetime opportunity and
probably an investment that can save their child if it were to become necessary. When
this researcher downloaded on Google "cord blood banking" in the Summer of 2008
there were over one million seven hundred thousand entries compared to Winter 2006
when there were approximately seven hundred thousand (Carr, I. personal computer
search, February, 2006 to July 10,2008). Now that stem cells harvestedfromUCB have
been successfully used for hemopoietic stem cell transplantation in unrelated adults
(Laughlin et al., 2004; Rocha et al., 2004; Sanz,2004; Kharaboyan, Knoppers, Avard, &
Nisker, 2007) they are actively being sought by families and researchers. Stem cells
harvested from UCB have been used to substitute for bone marrow as a source of
hemopoietic stem cells for transplants in the treatment of genetic disease, blood
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malignancies, and immune deficiencies (Kharaboyan, Knoppers, Avard, & Nisker, 2007).
The dedicated promise of private banking, coupled with pleas from public banks asking
mothers to donate UCB for altruistic purposes, can become confusing for pregnant
women as well as the general public. The empirical conclusion would be: Women who
know more about UCB banking are more likely to make appropriate choices for both
themselves and their families (Kharaboyan, Knoppers, Avard, & Nisker, 2007) and that
would be by deciding to donate umbilical cord blood. This researcher wants to know: do
they really do that and if they do, what is their understanding when they are making that
decision?
Banking is of two types i.e. public and private. A woman can donate cord blood
for an unrelated recipient to public banks (unrelated allogeneic transplantation). Private
(commercial) banks, on the other hand, offer expectant parents the option to store cord
blood for possible future use by that same child (autologous transplantation) or familial
use. Women and mothers-to-be need to have a balance of information presented to them
about private and public cord blood banking so they will feel comfortable to make an
informed decision.
Before deciding to privately bank UCB, women should be advised of both the
benefits and limitations of private banking. Considering one can guarantee easy access to
their own stem cells for themselves or for a family member with an actual need of stem
cell transplantation, it is equally important to inform mothers that presently it is highly
unlikely for a family with no history of blood diseases to ever need the banked UCB
(Fisk, Roberts, Markwald, & Mironov, 2005; Kharaboyan et al., 2007). This is in
agreement with The American Academy of Pediatrics (American Academy of Pediatrics
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[AAP], 1999 & 2007) who is against the private collection of cord blood as the need is
minimal. One of the reasons would be the research shared where two estimates
calculating the possible likelihood one would need the same blood given by the donor
(autologous) to range from 1:2,700 (Moise, 2005 and 2006) and another from 1:1,000 to
1:200,000 (Witte, 2005). This fact was recently addressed by Kingsbury (2008) in a
popular public news journal in the health section of that resource through the following
comment:
"Cord blood transplants also require a less perfect match in unrelated people,
opening up a broader spectrum of potential donors, and recipients' bodies are less likely
to reject a transplant" (Kingsbury, 2008, pp. 2-3).
The issue of private banking has generated controversy in recent years due to the
aggressive marketing tactics of some private collection-and-banking facilities. Large
numbers of organizations worldwide have started discouraging autologous or private
banking. In addition to the American Academy of Pediatrics (AAP) and American
College of Obstetrics and Gynecologist (ACOG), the Royal College of Obstetricians and
Gynaecologists' Scientific Opinion condemned the practice of private cord blood
blanking (Royal College of Obstetricians and Gynaeocologists, 2001, p. 2), and the
French National Consultative Ethics Committee and European Group on Ethics in
Science and New Technologies are discouraging its use (Agarwal, 2006;). Italy has
completely banned autologous and private banking (Rendine et al., 2000) by law and it is
forbidden by the Ministry of Health in China. Canada takes a similar view and has
published guidelines (Canadian Institutes of Health Research [CIHR], 2005; Armson,
2005). The Global Biopolitics Research Group out of Sydney, Australia has written a
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working paper titled: Umbilical Cord Blood: from Social Gift to Venture Capital which is
reflected by C. Waldby (2006):
Private cord blood banking has been largely condemned by bioethical and
medical professional bodies, on the grounds that the likelihood of any particular
individual needing a cord blood transplant is very low, and that public, redistributive
banking is a more efficient use of resources (p. 2).
The advantages and limitations to public banking of UCB should be clear before
making a decision. Public banking of UCB is to initiate use to a human resource for the
greater good of all. Public banks collect units from patients of a wider ethnic diversity.
Even though public banks are designed to improve donor matches for minorities, a recent
study revealed that cord blood donation from minorities has remained low. An American
Red Cross survey in 2001 showed that 64% of donors are white, 16% African American,
and 12% Hispanic, 4% Asian, 1% Native American, and 3% other (Ballen, Hicks, &
Dharan, 2002). In an effort to increase minority units, the IOM (Institute of Medicine)
report advised that 100,000 new quality umbilical cord blood units could be collected in a
national cord bank system (Institute of Medicine, 2005). For the marginalized patient, the
cost of personalized cord blood collection and storage is prohibitive and will be
addressed in detail in another section of the dissertation. When the studies keep
introducing and replicating the science of cord blood transplants from unrelated donors
coming from public banks which may succeed with one or two HLA mismatches (Moise,
2005), as novel therapies in the treatment of cystic fibrosis (Sueblinvong, Suratt, &
Weiss, 2007), transplantation for primary immunodeficiency (Gennery & Cant, 2008),
indications and donor selections for allogeneic stem cell transplantation in children with
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hematologic malignancies (Handgretinger, Kurtzberg, & Maarten Egeler, 2008), or issues
to consider for successful vaccinations in children with hemopoietic stem cell
transplantation (Patel, Chisholm, & Heath, 2008), one may start to agree that this is safe
and ethically therightoption for some families. Mothers may donate cord blood at the
time of delivery at no charge and are given access to suitable matches if the need ever
arises for immediate family members (Lui, 2006).
Insufficient dumber of Hemopoietic Stem Cells in Umbilical Cord Blood
The problem with insufficient number of precursor stem cells found in cord blood
can explain why familial use is unlikely going to be an advantage. Kurtzberg (2005)
conducted research showing that stem cells found in a unit of cord blood would not
suffice to treat adults weighing more than 110 pounds (Kurtzberg, Drapkin, & Sugarman,
2005). A major limitation when using cord blood grafts for transplantation in adults is the
concern that the grafts have a low number of stem cells as compared with bone-marrow
grafts (Laughlin et al., 2004). Reports of cord blood transplantation in adults suggest that
hematopoietic recovery is faster with higher cell doses (Laughlin, Barker, Bambach et al.,
2001; Sanz, Saavedra, Planelles et al., 2001; Ooi, Iseki, Takahashi et al., 2002; Laughlin,
2004). However, researchers are actively developing techniques to expand the number of
stem cells in a unit of cord blood, using them in clinical trials, and reporting that cord
blood transplantation in adults with leukemia and acute leukemia suggests that
hematopoietic recovery is faster with higher cell doses (Laughlin et al., 2004; Rocha et
al., 2004; Kharaboyan et al., 2007). Laughlin (2004) and Rocha (2004) were both
observational studies with expected limitations which are inherent in this environment. In
both, the effect of the stem cell source on various outcomes was analyzed by multivariate
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methods to allow for a controlled comparison and the two investigations differed in their
study populations and other methodological issues which may have influenced their
results (Sanz, 2004). With much of the work in laboratory technology progressing to
expand the UCB hemopoietic stem cells, the science is evolving so that this could solve
the issue of reduced number of stem cells in a unit and hopefully increase transplantations
to treat degenerative conditions such as rheumatoid arthritis and multiple sclerosis in
adults (Sanz, 2004; Copeland, 2006).
Another concern when a child is in need of an HLA (human leukocyte antigen) matched hematopoietic progenitor cell transplant (HPCT), but no match is available; the
affected child's parents can use Pre-implantation Genetic Diagnosis (PGD) to conceive a
child who is an HLA-matched sibling (Verlinksy, Rechitsky, Schoolcraft et al., 2001).
The sibling then can act as an umbilical cord blood donor for the child in need of the
transplant (Bick & Lau, 2006). This may not be the ethical choice of some parents and
thus is not a reliable alternative method for them to consider.
Information about Testing Diseases and Family History
Most diseases are the result of the interactions of multiple genes and
environmental factors. As genetic technology develops and tests become widely
available, it has been suggested that testing be carried out on umbilical cord blood stem
cells to identify pre-symptomatic diseases or disease susceptibility (McCullough et al.,
1994; Institute of Medicine of the National Academies, 2005, p.22, p. 169, pp. 180-183,
pp. 185-187). Delay in reestablishing normal immune functions as donor cells restore
recipient development of new lymphocytes, lymphohematopoiesis, plus
immunosuppressive therapy places patients at high risk for bacterial, viral, and fungal
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infections. In the case of donor-patient HLA (human leukocyte antigen) disparity,
infection is an even greater problem (Eastlund, 1995; Institute of Medicine of the
National Academies, 2005; Kharaboyan et al., 2007). Usually as a general rule the tests
that are applied are the same series of test used for the deferral criteria as that of whole
blood donors for risk factors. To reduce the risk of transmission to the recipient the
criteria to determine which units are suitable for banking and the tests that umbilical cord
blood subjected to include: ABO and RH type determination, newborn screening
retention samples, infectious disease markers, HIV/AIDS, Hepatitis A, Hepatitis B,
Hepatitis C, CMV by culture or DNA PCR testing, Treponema pallidum (syphilis),
human T-cell lymphotropic virus, West Nile virus, parasitic blood diseases,
hemoglobinopathy screen such as test negative for homozygous hemoglobinopathies,
microbiology tests as positive CFU growth, normal genetic screen to mention a few
(Warwick, R & Armitage, S. 2004; IOM, 2005).
Umbilical Cord Blood transplantation requires a careful and thorough review of
the mother's medical and social history to exclude those with a transmissible disease
(Ballen, 2005). This may involve inquiry into the mothers' symptoms of potential
infectious diseases as listed above or the mother has engaged in behaviors or received a
medical treatment that increases the risk of contracting these diseases. In addition, if there
is a lack of family medical history of inherited genetic disorders or diseases, if there is
inappropriate affirmative responses to questions from risk behavior questionnaires, or if
there is refusal to answer maternal and baby health questionnaire eligibility these may
affect inclusion or non-inclusion criteria for the bank when one is desiring to send the
UCB unit (Institute of Medicine of the National Academies, 2005, pp. 168-171). When
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information about banking is shared with this population from a health care provider,
especially public banking, health professionals must inform mothers about what
infectious disease agents are being tested for, possible genetic testing the unit will
undergo, and how they plan to be informed if the results are positive. This is a critical
part in the intake process of public banking. This may reveal information about paternity,
infectious diseases and predisposition or susceptibility to certain genetic diseases.
If confidentiality is not properly protected, respected, and safeguarded the results
of testing can have psychological and social implications for the parents and potentially
put children at risk of suffering insurance-, education-, and employment-related
discrimination (Kharaboyan et al., 2007). It is essential to respect the privacy and the
health needs of women and their children as well as the privacy of the patients receiving
the transplants (10M, 2005). Knowledge of individual risk does not always lead to better
health but it will allow better prevention, diagnosing, and more avenues of approach in
treatment (Guttmacher, Collins, & Carmona, 2004). This will ensure that increased
knowledge leads to opportunities of choice affecting improved health outcomes.
Today, with medicine at the crossroads in the era of the genomic frontier, the
valuable tool is the family history (Guttmacher et al., 2004; Rich, Burke, & Heaton,
2004; Scheuner, Wang, Raffel, Larabell, & Rotter, 1997). Computerized software allows
clinicians the advantages of standardizing the family history and helping to overcome the
gaps in obtaining and organizing the data. Linked records allow donors and recipients to
be found, informed, and referred for care if infectious or genetic diseases detected after
UCB stem cells have been transplanted (McCuUough et al., 1994). Doctors are allowed to
retrace the donated UCB in the event that a child requires an autologous transplant. Also,

in the event where a new genetic or infectious disease test becomes available, access to
linked stored samples would allow providers to recontact donors who have previously
agreed through informed consent to permit conducting tests on their previously donated
samples, giving them the possible benefit of early diagnosis and treatment (Pinch, 2001).
Many observers worry that recording the family history may lead to genetic
discrimination in employment or health insurance (Guttmacher et al., 2004), especially
when anything that is noted about the family members in the medical record is potentially
discoverable as publicized in the Fall 2003 Veterans Administration Electronic Medical
Record scandal (personal communication with Paul D. Zalusky, September, 2003) and
witnessed by this researcher May, 2008 with medical records stolen from University of
Utah Medical Center, Salt Lake City, Utah. Many states have laws in place to prohibit
such discrimination (see www.genome.gov/policyethics/legdatabase/pubsearch.cjm for a
state-by-state listing of such laws) (Guttmacher et al, 2004), and national legislation has
been passed to incriminate those who violate the law. Beginning in 2004 are documented
surveys that gives one reason to believe many people will welcome efforts to make the
family history a more available tool. P. Yoon and M. T. Scheuner from the Center for
Disease Control and Prevention, Office of Genomics and Disease Prevention had a
personal communication with Dr. Alan Guttmacher from the National Human Genome
Research Institute at the National Institute of Health where they asked more than 4000
people the question "How important do you think knowledge of your family's health
history is to your personal health?" Seventy-three percent of the survey respondents
thought it very important, and 24 percent thought it somewhat important. However, only
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30 percent of the respondents reported that they had actually collected health information
from relatives in order to develop a family health history (Guttmacher et al., 2004).
A more recent example of this is atimelyinitiative, July 16,2008, where there
was a national launch of "My Records at MinuteClinic", a secure website that allows
patients to view their MinuteClinic medical records online. This is the first retail clinic to
partner with Google Health to help patients manage their medical information online.
With the celebration in November 2007 seeing one million patients as a marker in the
retail clinic competition, they are anticipating this successful. When a patient joins "My
Records at MinuteClinic", they can also link their MinuteClinic records to a personal
Google Health account. This was tested over several weeks in the Chattanooga and
Knoxville markets and they have seen significant and positive interest from patients. This
is done by offering the service at the patient sign-in kiosk and collecting their email
address if they wish, however, it is not required to obtain health services. The patient is
given a card with information how to access this website and to follow steps to register
online securing two passwords to link them on their individual record. Partnering with the
secure website, Google Health, it reassures those who fear a potential breach of
confidentiality is far less likely to occur (personal communication on July 16,2008 with
Alex Bollman, Project Manager, MinuteClinic, 920 Second Ave. S., Suite 400,
Minneapolis, MN 55402).
Financial Commitment
Thefinancialcommitment is an issue to consider. Private Banking, sometimes
found in the literature as commercial or family banking, fees include an upfront fee for
families in private banking between $1,100 and $1,975 and an annual charge for ongoing
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storage about $115 to $125 (Gajilan & Gupta, 2005; Gunning, 2006; Young, 2006;
www.cryo-cell.com/resource-center retrieved on October 18,2006). Public Banking fee
is initially free to the parents but the cost for the initial processing of cord blood is about
$1,000 per unit stored. The bank incurs this initial cost and may try to recover some of
the costs later. They can charge the insurance companies for units used with transplants
once the need evef arises for the individual. Fees usually average $15,000 to $35,000 per
unit (Gunning, 2006; Moise, 2005; Young, 2006) (see Appendix G for a comparison
between the public banking systems of the United States and Europe with the private
banking systems of the United States and Europe).
The Asian and Indian scenario with public and private banking is a little more
limiting. Table 1 of Appendix D gives the picture of umbilical cord stem cell banking and
transplants in Asian countries. In India, there are no public umbilical cord blood banks
available, although, attempts have been started in New Delhi and Chandegarh. In the
private sector there are a few of them. Public banking would be more useful as it would
benefit all, it would be cheaper as the costs are likely to be provided by government
agencies and it may be useful for the minor ethnic groups. Private banks are useful for
one who can bear the costs and hence it is expensive. It is not available to others
including minor ethnic groups. Reliance Life Sciences (RLS) established the country's
first umbilical cord blood bank (cord blood repository-CBR) in 2002. It has two programs
i.e. Relicord A which collects donor umbilical cord stem cells for unrelated allogeneic
transplants and Relicord S which collects for related sibling transplants. There are banks
located at Bangalore, Chennai and other places. With the education status of mothers in
India being poor, most of the women are not involved in decision-making and therefore

legally valid consent remains a rarity. Only 34 % of deliveries occur within the
infrastructure of health facilities and skilled personnel attend to only 42% of deliveries
(Agarwal, 2006).
Regulation and Quality Assurance
The cord blood banking industry has been unregulated during its inception in the
early 1990's when umbilical cord bank processing and cryopreservation activities had
markedly evolved from laboratory activities (McCullough, McKenna, Kadidlo,
Schierman, & Wagner, 2005). Since 1995, the Food and Drug Administration (FDA)
engaged in thorough public discussion regarding a proposed regulatory approach for
hematopoietic stem/progenitor cells obtained from placental/umbilical cord and
peripheral blood (Harvath, 2000). In February 1997, the FDA announced its "Proposed
Approach to Regulation of Cellular and Tissue-Based Products" (Food and Drag
Administration, 1997). This plan was a comprehensive, risk-based system of regulation
for cellular and tissues through innovative cellular and gene therapy products (Harvath,
2000). Because standards have evolved over time, cord blood banks contain units that
have different levels of quality. Some units have been placed in the usable inventory with
incomplete test results and/or documentation and may not meet the bank's own current
criteria:
"There is a tension between private cord blood banks, which store blood for
autologous or family use, and public banks, which store blood for unrelated use. There is
an inference that private banks are taking out of circulation cord blood units which might
otherwise be used for unrelated recipients. It is not clear that this is the case since public
banks restrict their collection to a local network of hospitals and it is difficult for women

outside their target population to donate. Private banks have no such restrictions"
(Gunning & Holm, 2006, p. 19).
In January 2005, Bone Marrow Donors worldwide reported the U. S. inventory of
public cord blood banks from unrelated donors to be in excess of 87,000 units (Moise,
2005). It is estimated that half of these units did not meet the criteria for a usable unit
based on cell count and other collection issues (Institute of Medicine [IOM], 2005). One
of the problems is the lack of enough quality cells and volume to benefit a treatment for
adults. Since that time, the problem of cell count is being address mostly validated in
mouse models (Encabo, Mateu, Carbonell-Uberos, & Minana, 2003; Jaroscak, Martin, &
Waters-Pick, 1998). One of the initial studies addressing cell count out of The Chinese
University of Hong Kong by Tsang et al., (2001) where a comparative laboratory trial
with dextran added to bags containing umbilical cord blood (UCB) occurred. This was
followed by sedimentation for 30 minutes pre and post sample in a semi-closed system
which enabled volume reduction of UCB without significant quantitative and qualitative
losses of nucleated cells (Tsang et al., 2001). There is a surge of science that is trying to
address this issue (Bornstein et al., 2005).
As mentioned earlier until recently there has been virtually no regulation of cord
cell banks. In March 2004 the European Directive (2004/23/EC) on setting standards for
quality and safety for the donation, procurement, testing processing, preservation, storage
and distribution of human tissues and cells came into force (Gunning & Holm, 2006,
p.21). This tissue banking directive would apply to all biobanks, including cord cell
banks in the public sector. In the UK the Human Tissue Act 2004, which meets the
Directive requirements, came into force on April 1,2006. Other countries, notably

Australia, Germany, and France already impose good manufacturing practice (GMP)
standards. Most other locations standards apply which have been developed by bone
marrow transplant organizations or blood services such as the Foundation for the
Accreditation of Cellular Therapy (FACT) and the American Association of Blood Banks
(Gunning, 2004, pp. 10-15). Gunning (2006) also mentions there have probably been over
a dozen organizations around the world setting quality standards for cord blood banking,
all varying slightly, and accreditation has been voluntary.
Cord blood banking involves: recruitment, consent, testing of maternal donors,
collection, processing, cryopreservation, testing, and releasing cord blood unit to a
transplant center. In the USA protocols have been established for these (Rubinstein,
Dobrila, & Rosenfield, 1995) and updated in 2005 with the establishment of a National
Cord Blood Stem Cell Program funded by the Health Resources and Services
Administration with $10,000,000 (Institute of Medicine, 2005) but this expenditure will
await a report on the issuefromthe Institute of Medicine. Meanwhile there is
disagreement between cord blood banks and registries as to how the program should
work (Reed, A. from New York Times, May 29,2004). The establishment of the program
would allow for easy access to donors of different ethnic and racial populations. Units in
public banking would be registered in a computerized program and able to be located in a
search without the initial cost as in private banking. The units are tested for viruses,
transmissible infectious diseases, and bacterial contamination during the prep for
banking, so all is available in a shorter time interval. Relocation of the parents is a barrier
to this process. The rational to contact the parent of the donor is to identify any serious

illness identified since the birth of the donor. The parents have the right to decline to
participate (Witte, 2005).
Even though public banks are designed to improve donor matches for minorities
by helping serve those patients who have a more difficult time finding donors through the
National Marrow Donor Program (NMDP) and other international registries, a recent
study revealed that cord blood donation from minorities has remained low. An American
Red Cross survey in 2001 showed that 64% of donors are white, 16% African American,
12% Hispanic, 4% Asian, 1% Native American, and 3% other (Ballen, Hicks, & Dharan,
2002). In an effort to increase minority units, the IOM (Institute of Medicine) report
advised that 100,000 new quality umbilical cord blood units could be collected in a
national cord bank system (Institute of Medicine, 2005). As of May 2005 the racial/ethnic
composition of the NMDP cord blood registry 52% white, 5% African American, 13%
Hispanic, 5% Asian, 12% multiple race, 1% Native American, and 12% other or
unknown (Ballen, 2005). This implies an increased recent attention to minority
recruitment has resulted in more diverse cord blood units.
On December 20,2005 President Bush signed into law H.R. 2520. Congress
passed the Stem Cell Therapeutic and Research Act (Lui, 2006). The bill renames the
National Marrow Donor Program the C. W. Bill Young Cell Transplant Program (Moise,
2006). Along with this, $34 million in 2006 and $38 million between 2007 and 2010 are
appropriated to establish a national cord blood inventory of 150,000 units. The belief is
that would then be enough diversity that 90% of Americans who might need stem cells
would be able to find a match (U.S. Congress, 2005). The bill also tasks the FDA with
the development of licensing requirements for cord banks that will contribute units to the

inventory. In early 2006 the California Assembly Initiatives, Assembly Bill (AB34)
Portantino-Umbilical Cord Banking, Pilot Project was effective July 1,2007. This was a
pilot project that would seek to diversify the umbilical cord blood supply collected in
public blood banks. It would require the Department of Public Health to identify 5
hospitals, in ethnically diverse areas, as voluntary participants to collect, secure a
patient's consent for donation of, and partner with specified entities to store umbilical
cord blood (A Publication of the Regional Perinatal Programs of California, 2007). In
addition Senate Bill, SB 1555: Speier-Umbilical Cord Blood Banking, Education,
Screening which will provide awareness, assistance, and information regarding umbilical
cord blood banking options in multiple languages should be an introduction in trying to
change the social and cultural perspectives of this practice in California.
Cord Blood Banking in Regenerative Medicine
The aspect of umbilical cord blood banking has gained particular impetus from
the field of regenerative medicine. Regenerative medicine seeks to identify the
mechanisms of self-production involved in auto-regeneration and to enhance and develop
them into therapies for those tissues that do not regenerate spontaneously. Research is
being conducted to find ways to culture cord blood stem cells so they can be "expanded"
in the same way as embryonic stem cell lines (Egan, 2000) and to induce
transdifferentiation into multipotent stem cells, rather than stem cells committed to the
production of the blood system (Anderson, Gagae & Weissman, 2001). Umbilical cord
blood is being used for unrelated bone marrow replacement, for example the report out of
Japan (Mugishima, Takahashi, Nagamura, Asano, & Saito, 2002). The cord blood bank

industry is open to paths of stem cell research and wants to participate in alternative
options (Tse & Laughlin, 2005; Klatz, 2005; Henning et al., 2004).
Although traditionally associated with industrialized nations, epidemic levels of
non-communicable diseases, such as diabetes, cardiovascular diseases and cancer are
rapidly increasing in low- and middle-income countries (Cryo-cell, 2006) on top of the
persisting threat of infectious disease such as in India with malaria and anemia
(Bhattachary, 2006). Now threaten by the developing world and straining health systems
that are still struggling with persisting levels of infectious disease cord blood banks may
be an asset. It is like there is a "double-burden" on these countries. The emerging field of
regenerative medicine may provide new opportunities to address these health needs if
employed with the goal of improving global health over all (Greenwood et al., 2006).
Greenwood further implies several developing countries themselves have recognized the
potential of regenerative medicine and have initiated Research and Development work in
thisfield.This phenomenon of the "double burden" is so severe that the World Health
Organization refers to non-communicable diseases in the developing world as "neglected
epidemics" (World Health Organization [WHO], 2003, p. 15). "Worldwide, noncommunicable diseases now account for more deaths annually than infectious diseases",
(http://www.who.int/dietphysicalactivity/publications/facts/chronic/en. Retrieved May
10, 2007). By 2020, it is estimated that 7 out of 10 deaths in developing countries were
due to non-communicable diseases (Boutayeb & Boutayeb, 2005).
In Greenwood (2006) he discusses based on the literature regarding health
innovation in developing countries (Juma & Yee-Cheong, 2005; Morel, 2005), as well as
experience in studying successful biotechnology sectors in developing countries

(Thorsteinsdottir, Quach, Daar, & Singer, 2004), how he and his colleagues believe that
building capacity and encouraging local innovation in regenerative medicine can help
developing countries capture benefits to address some of the health needs presented by
this "double burden" of non-communicable and infectious diseases. Five areas where
assessed: dedicated government funding, goods (e.g. bioengineered skin) and services
(e.g. umbilical cord blood banking available for purchase), companies, publications, and
academic institutions (see Appendix E for a reflection of a survey of regenerative
medicine activities in 31 low- and middle-income countries). Greenwood further presents
a more detailed descriptive narrative of six countries currently active in regenerative
medicine: Argentina, China, India, Iran, Malaysia and South Africa. These countries were
chosen because they show interesting and diverse activities in regenerative medicine, as
well as representing various geographic regions of the world. The information in the
narratives is well beyond the scope of this paper; however, the results of this survey of
regenerative medicine activities in developing countries demonstrate that even though
regenerative medicine is still an emerging field worldwide, developing countries are
actively engaged in its pursuit. The survey identified 31 low- and middle-income
countries and is a first step towards understanding how developing countries are building
capacity in regenerative medicine and using it to address some of the health needs such as
diabetes, cardiovascular disease and cancer. An understanding such as this can facilitate
the development of health and policy both in developed countries and developing world
needs.

Unique Problems with Umbilical Cord Blood
In an earlier portion of the study this researcher described the issue of umbilical
cord blood being discarded at the birth as waste material (Gluckman, 2000; Kingsbury,
2008). With education and the science evolving over the years on the use of UCB for
treatment of multiple diseases (Perlow, 2002, Moise 2005) the collection rate is
improving but it still needs to improve (Institute of Medicine of the National Academies,
2005). Especially if infectious disease or genetic testing indicates that a child's cord
blood is not suited for storage and transplantation or when the volume or quantity of cells
collected is insufficient, the units may be considered not useable and then discarded
(Kharaboyan et al., 2007). Ballen (2005) reported a common reason for approximately
half of the cord blood units intended for banking after successful collection are not frozen
and stored for transplant use due to a low-volume in the unit (Ballen, 2005). Now one is
trying to educate hospital managers and obstetrical providers such as physicians/nursemidwives/nurses to re-think this and instead of discarding these units, stem cells
scientists have requested access to them to advance research in stem cell therapy (H6maQuebec, 2006). This possibility should be discussed with women when obtaining
informed consent before the banking process (Institute of Medicine of the National
Academies, 2005; Gunning, 2006, Chapter 3, pp. 17-25).
The problem has surfaced where reports of some private companies collecting
umbilical cord blood are presenting themselves as "Public Banks" (Gunning, 2006;
(Saginur, Kharaboyan, & Knoppers, 2004). One of the tactics reported by Hundley
(Hundley, 2003) is that they store blood in gratuitously and then sell compatible matches
to research companies as well as to patients in urgent need of transplantation who are
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willing to pay close to $15,000,000 per unit. Hundley goes on further by indicating the
incentives to recruit women have been reported to pay obstetricians a fee for collecting
cord blood from their patients (Kharaboyan, 2007, Gunning, 2006). The provider ought to
fully disclose their personal commercial interests as well as those of the company with
whom one chooses to store the cord blood (Institute of Medicine of the National
Academies, 2005, Chapter 5, pp. 106-119; Gunning, 2006).
It is ethically important to obtain informed consent for the donation of any cord
blood unit regardless of the timing of collection or the potential use of the unit. Informed
consent procedures for the donation of cord blood should follow a consistent set of
protocols that educate the donor about the various options for cord blood use. The
requirements should be modeled on already established criteria for transfusion of whole
blood and other unfrozen products (Fernandez, 1998; Institute of Medicine of the
National Academies, 2005, p. 107). Different consent methods have been used by
different cord blood banks (Institute of Medicine of the National Academies, 2005,
p. 108).
The most optimal manner to promote and ensure respect for a pregnant woman's
autonomous choice, her informed consent for the collection, storage, and use of her cord
blood should be given prior to the labor experience and after adequate disclosure of
information on the uses of the donated cord blood. This is especially important in the
alternative of public banking, in which the patients may often not initiate the donation
process. Almost all the women polled in Sugarman's (Sugarman, Kurtzberg, Box, &
Horner, 2002) study expressed the opinion that the information about the collection of
cord blood should be presented before the third trimester of pregnancy and could be
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included in the informational packets that are given to others during prenatal visits. On
the other hand, knowing that situations for optimal conditions may not occur in the labor
and delivery area, the American Red Cross Cord Blood Program, North Central region,
investigated a phased consent policy (Vawter, Rogers-Chysler, & Clay, 2002). The
phased consent approach is a 3-step process involving (1) targeting information about
cord blood banking to pregnant women; (2) allowing early labor consent to the ex utero
collection, which is the collection from the placenta shortly after the birth experience, and
temporary storage of cord blood; and (3) permitting post collection consent to the
permanent storage, donation, and testing of the cord blood. Mothers who were eligible for
intrapartum labor consent had to meet strict eligibility criteria including dilation less than
7 cm, age older than 18 years, more than 36 weeks gestation, and no use of narcotics.
Theoretical Model
The transtheoretical model (TTM) of change provides an alternative way of
grouping patients according to their stage of readiness to leam and adopt new beliefs and
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by
understanding the clients' readiness to change we can design our intervention to increase
the chance of successful implementation (Haslam & Haslam, 2000). The dimensions
described in the model, the stages, processes, context, and markers of change, are
designed to assist in picturing and understanding the process of change (Prochaska &
DiClemente, 1984; DiClemente & Prochaska, 1998, pp.3-24; DiClemente, 2003). TTM
incorporates elements of various theories of therapy, learning, and behavior change,
hence the term 'Transtheoretical'. However, the model does not try to resolve all the
conceptual issues and conflicts among the various theories incorporated in the model. It

simple tries to identify and describe important elements of the process of intentional
behavior change (DiClemente, 2007). Central to this model is the idea that people move
through pre-defined stages when trying to improve health-related behavior. The stages
are:
•

Pre-contemplation (no consideration of changing)

•

Contemplation (thinking about changing)

•

Preparation (making plans to change)

•

Action (actually in the process of changing)

•

Maintenance (working to prevent relapse)
Targeting interventions according to a person's readiness to change is not a new

idea in the world of health promotion. Prochaska and DiClemente (1982) developed the
"stage of change model" in the field of psychotherapy in the 1980's. The model was
originally seen as a linear model but now is often considered as cyclical because most
people attempting to change their health behavior will have to repeat stages in order to
learn how to maintain their behavior. The cyclical model is shown in the diagram in
Figure 1, Appendix C (Prochaska and DiClemente, 1982; Prochaska & Levesque, 2001).
This model is often used to design a course of action to encourage people to give
up smoking. For example, a smoker who is in the pre-contemplation stage will need to be
given graphic information about the health risks (Haslam et al., 2000) and may benefit
from shock tactics. However, those smokers in the preparation stage will benefit from
encouragement, practical advice on how to change, information to reinforce their
motivation and perhaps skills training.
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The same principles can be used for pregnant women learning about cord blood
collection, banking and storage of her infant's blood at the time of birth. If she has asked
for assistance in understanding the process, we could presume that she is past the precontemplation stage. However, if she is seeking information to make a decision regarding
public or private banking she may be further in the stages of readiness to change through
preparation (making plans to change) or action (actually in the process of changing) thus
making a decision.
The transtheoretical model (TTM) of change provides an alternative way of
grouping patients according to their stage of readiness to learn and adopt new beliefs and
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by
understanding the clients' readiness to change we can design our intervention to increase
the chance of successful implementation (Haslam & Haslam, 2000). The dimensions
described in the model, the stages, processes, context, and markers of change, are
designed to assist in picturing and understanding the process of change (DiClemente,
2003; DiClemente & Prochaska, 1998, pp.3-24; Prochaska & DiClemente, 1984). The
cyclical model is shown in the diagram in Figure 1, Appendix C (Prochaska and
DiClemente, 1982; Prochaska & Levesque, 2001).
The same principles can be used for pregnant women learning about cord blood
collection, banking and storage of her infant's blood at the time of birth. If she has asked
for assistance in understanding the process, we could presume that she is past the precontemplation stage. However, if she is seeking information to make a decision regarding
public or private banking she may be further in the stages of readiness to change through
preparation (making plans to change) or action (actually in the process of changing) thus

making a decision. A Stage of Readiness Scale was used and adapted from Prochaska et
al., (Prochaska, Velicer, & Rossi, 1994; Quinn, Alexander, Hollingsworth, O'Connor, &
Meltzer, 1994) (see Appendix H, Table 1).
It is important to address any assumptions or motivations the donors might have.
The attitudes of mothers toward the collection of cord blood units generally reflect their
level of knowledge of the process (Sugarman, Kaplan, Cogswell, & Olson, 1998;
Fernandez, Gordon, Van den Hof, Taweel, & Baylis, 2003). Perceptions about the
collection process can be misleading, the associated risks, and the availability and access
of units, should they be needed in the future, are common among cord blood donors. In
one study, women failed to appreciate their alternatives to donating cord blood to a public
bank. Almost thirty-three percent (33%) did not understand that they had the option of
discarding their cord blood at delivery, whereas just overfiftypercent (50%) were aware
of the option of placing cord blood units in a private bank (Sugarman, Kurtzberg, Box, &
Horner, 2002). Another study showed that ninety-five percent (95%) of new mothers say
had they known about public cord blood donation, they would have donated per a recent
report (Kingsbury, 2008) of a National Marrow Donor Program (NMDP) survey.
"The potential is so significant," says Dr. Jennifer Willert, a stem-cell transplant
specialist at the Rady Children's Hospital in San Diego. "Not to have families know
about the possibility of banking, that's tragic." (Kingsbury, 2008)
Other donors view public banking as a less expensive way to preserve and gain
access to their children's cord blood in the future rather than contracting with a private
bank. Almost one-half of the respondents indicated that the reason they chose to donate
their cord blood to a public bank was to protect their child's future health (Sugarman et
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al., 2002; Institute of Medicine of the National Academies, 2005, p. 111). Not having a
property claim on public donation of cord blood is an important issue parents need to
comprehend at the time of informed consent.
The researcher was interested in examining whether the variables of age,
gestational age, level of parity (number of children), marital status, race/ethnicity,
religion, highest level of education completed, economic status and method of payment
for prenatal care are predictors of knowledge of cord blood donation.
Umbilical cord cell transplantation has evolved over the last 15 years from being
an experimental procedure to an accepted treatment for a number of hematological
diseases and genetic disorders. During the evolution the banking of this human tissue has
increased exponentially around the world. The proliferation of private cord cell banks has
been particularly strong in the USA and Asia while, in Europe, where there are one or
two old established private banks, the emphasis has been on public cord cell banking.
But, whether in the private or public cord cell banking sector, there remains alternate
quality assurance standards that need addressing. This will become particularly important
if cord blood stem cells are to play an important part in the cellular therapies of
regenerative medicine in the future. As the utility of these cells increases countries may
have to consider whether cord blood should be collected from all newborns. This will be
a costly process and maybe the promotion of cord blood donation but with the
acknowledgement that the right to private storage may prove a practical way forward for
some and not for others. It is also clear within this frontier of science that new ethical
questions will continue to arise.
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Implications to the Body ofNursing Science & Gaps in the Literature
Essentially the limited or absence of nursing science, theory building and research
in this field of contributing stem cells in cord blood collection, donation, and future
outcomes needs to be recognized and further supports the need for this study. The
following are areas where there is a gap in the literature supported by my prior literature
review:
•

Knowledge deficit on types of banking for cord blood: Private and Public

•

Knowledge deficit on what process of regulation matches private versus public
blood banks

•

Disagreement on insufficient number of hemopoietic stem cells in umbilical cord
blood and how it needs to be packaged

•

Discrepancies regarding information related to testing for diseases and what is
needed in the family history

•

Discrepancies related to thefinancialcommitment

•

Issues surrounding what are the required regulatory and quality assurance issues of
collection, donation, and storage

•

What avenues of disease treatment and regenerative medicine are presently
occurring and what is to come in the future.

(Kingsbury, 2008; Institution of Medicine(IOM), 2005 & 2006; Kurtzberg, Drapkin, &
Sugarman, 2005; Eastlund, 1995; Kharaboyan et al., 2007; Gunning & Holm, 2006;
McCuUough et al., 2005; Greenwood, 2006).

Chapter III
Methodology
Method reflects the researcher's philosophical beliefs about the nature of reality
and is situated in, and flows from, one's world-view and the nature of the question being
researched. According to van Manen, "Lived experience is the starting point and the end
point of phenomenological research" (van Manen, 1997, p.36). Lofland addresses the
lived experience when he stated, "Today's solutions may become tomorrow's problems;
tomorrow's problems may provide special research opportunities the day after" (Lofland,
Snow, Anderson, & Lofland, 2006, p. 32). The research process begins with the
awareness of a phenomenon as it exists in the world. Who would have known thirty-five
years ago when this researcher a new graduate nurse routinely collecting cord blood at a
birth to determine the baby's blood type that some day one would be collecting it for
stem cell research on a baby. This researcher has chosen to do a quantitative method
because qualitative results are inadequate by themselves. When the researcher assesses
the initial quantitative results the qualitative data are needed to help explain or build what
is really going on with the sample (Creswell & Piano Clark, 2007, Chap. 4 & 5). The
researcher has chosen to do a Survey Design which may hopefully lead to research
opportunities in the future with a mixed method as an Explanatory Design.
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The purpose of this chapter is to describe the quantitative design and methods
chosen to conduct this research. The qualitative analysis was limited to only 11
interviews out of the total, thirty in the population, for this study and there was limited
time to go into depth due to time constraints and financial limitations. This is an area the
researcher needs to explore in the future. This section begins by addressing the research
questions and hypotheses, the specific research design implemented, including the
desired sample, recruitment of participants, and measurement instruments. This includes
a discussion of descriptive and inferential statistics used to analyze the data, data
collection procedures, and data management and analysis. Issues related to human
subjects discussed, which includes confidentiality, consent,risks/benefits,and
communication with participants.
Method
Research that includes uncovering meaning from a feminist perspective is a
beginning step towards understanding a woman's lived birth experience. Because much
of a woman's lived birth experience is hidden due to privacy and it being one of the most
intimate moments in her life, a. feminist hermeneutic phenomenologicol perspective was
used to provide deeper understanding of the lived experience of women and the decision
to donate cord blood at her child's birth. The Survey Design is well suited to this study
because it is a step toward how to assess a woman's knowledge in the use of this method
of stem cell collection. The design is suitable as the researcher wants to form groups
based on quantitative research (Morgan, 1998; Tashakkori & Teddlie, 1998) and the
researcher will use the quantitative participant characteristics to guide purposeful
sampling for a qualitative phase (Creswell, Piano Clark, Gutmann, & Hanson, 2003) in

future research opportunities. The researcher anticipates one may need qualitative data to
explain significant or non-significant results, outlier results, or surprising results (Morse,
1991).
Stem cells from umbilical cord blood form one of the most commonly banked
types of human tissue. Birth is a time when stem cell collection is an option through
umbilical cord blood collection. Despite over 74 million births per year in the world of
which four million in the United States (World Watch Institute, 2006, p.75), many people
remain unaware of human umbilical cord blood collection (Cryo-cell, 2006). Originally
stored for the treatment of hematological disorders these stem cells have now been found
to be more versatile for potential use in the treatment of a broader range of disorders and
diseases and may be particularly valuable in cell therapy and regenerative medicine
(Gunning & Holm, 2006, p. 17;Waldby, 2006).
The storage of umbilical cord cells has not been without controversy and there is a
rapidly growing private sector involvement. Over the last two decades umbilical cord
blood has proved an effective substitute for bone marrow in the treatment of blood
disorders, and most nations in the developed world have public programs for the
harvesting and storage of cord blood for allogenic transplantation (Garcia &
Torrabadella, 2006; Waldby, 2006). Yet, a number of ethical issues continue to be
debated involving questions of regulation and quality assurance, ownership and
commercialization and patenting. In this paper the researcher will first present the
historical background of related and unrelated cord blood to establish the legitimacy of
the science, public versus private banking, regulation and quality assurance of banking
and the worldwide influence cord blood banking has on regenerative medicine.

Tremendous confusion remains about different sources of stem cells and their use
in the minds of the government, the public, and the medical community. Until 1988
(Smith & Thomson, 2000) and April, 2006, (Cryo-cell, 2006) blood that remained in the
umbilical cord and placenta respectfully after delivery used to be routinely discarded.
Now several studies have confirmed with similar results this blood is known to contain
hematopoietic stem cells and pluripotent mesenchymal cells (Moise, 2005);
undifferentiated cells that can develop into virtually any type of blood cell in the human
body; and provides a better alternative to bone marrow transplantation to treat an
expanding list of malignant, benign, and inherited disorders (Perlow, 2002) (see
Appendix B for a list of diseases treatable with stem cells from umbilical cord blood).
The purpose of this study is to investigate pregnant women's knowledge of cord
blood collection and what decision-making process they experience for a decision on
donation of cord blood. The research question: What characteristics during a woman's
pregnancy are related when making a decision for cord blood donation at birth?
The following hypotheses were tested and are listed below:
Hypotheses:
1) Women are not knowledgeable about their options to store infant's cord blood
(CB) with a storage bank for possible future use by the child or other family members.
The transtheoretical model (TTM) of change provides an alternative way of
grouping patients according to their stage of readiness to learn and adopt new beliefs and
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by
understanding the clients' readiness to change we can design our intervention to increase
the chance of successful implementation (Haslam & Haslam, 2000). The dimensions
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described in the model, the stages, processes, context, and markers of change, are
designed to assist in picturing and understanding the process of change (DiClemente,
2003; DiClemente & Prochaska, 1998, pp.3-24; Prochaska & DiClemente, 1984). The
cyclical model is shown in the diagram in Figure 1, Appendix C (Prochaska and
DiClemente, 1982; Prochaska & Levesque, 2001).
The same principles can be used for pregnant women learning about cord blood
collection, banking and storage of her infant's blood at the time of birth. If she has asked
for assistance in understanding the process, one could presume that she is past the precontemplation stage. However, if she is seeking information to make a decision regarding
public or private banking she may be further in the stages of readiness to change through
preparation (making plans to change) or action (actually in the process of changing) thus
making a decision. A Stage of Readiness Scale used adapted from Prochaska et al.
(Prochaska, Velicer, & Rossi, 1994; Quinn, Alexander, Hollingsworth, O'Connor, &
Meltzer, 1994) (see Appendix H, Figure 2).
The researcher is interested in examining whether the variables of age, gestational
age, level of parity (number of children), marital status, race/ethnicity, religion, highest
level of education completed, economic status and method of payment for prenatal care
are related characteristics to the knowledge of cord blood donation.
Research Design
This research presents a survey with a descriptive correlation design using
convenience sampling, utilizing a cross-sectional design to assess factors that may lead to
cord blood collection, banking and storage. The design will use t-testfor independent
means and Analysis of Variance (ANOVA) for analysis. The design and method are

intended to determine if the knowledge level of two factors: public cord blood banking
and storage OR private cord blood banking and storage is clearly understood by pregnant
women and their partners. Since the goal is to predict values of the dependent variable,
cord blood banking (public or private), which is categorical and dichotomous, the
researcher is attempting to predict membership into one of two or more "groups". The
researcher is testing if there is statistical significance between the differences of the two
sample means. A statistician named William Gosset developed the t-test for exactly this
type of situation (Fred Pyrczak, 2010, p. 119). As a test of the null hypothesis, the t-test
yields a probability that a given null hypothesis should be rejected. When the t-test yields
a low probability that a null hypothesis is correct, the researcher usually rejects the null
hypothesis. There are three basic factors which interact with each other in determining
the probability level: 1) The larger the samples, the less likely that the difference between
two means created by sampling errors. When large sample are used, the t-test is more
likely to yield a probability low enough to allow rejection of the null hypothesis than
when small samples are used. 2) The larger the observed difference between the two
means the less likely that the difference created by sampling errors. 3) The smaller the
variance among the participants, the less likely it is that the difference between two
means created by sampling errors and the more likely the null hypothesis rejected (Fred
Pyrczak, 2010, p. 120; Shott, 1990, pp. 122-125).
The other analysis which was used was the One-Way ANOVA. Analysis of
variance (ANOVA) is a closely related statistical procedure to the t-test but is used to test
the difference(s) among two or more means (Holcomb, 2009, p. 149; Fred Pyrczak, 2010,
p. 127). The t-test cannot give you the difference among more than two means. When

ANOVA is done, the result also uses similar methodology to the t-test to determine if
there is a statistically significant difference in means by calculating in F-value.
One advantage of the research design is the ease which the use of the instruments
will provide, as well as their brevity. Another potential advantage includes patients
understanding of private versus public banking and the process in each bank. It will
minimize potential confusion to pregnant women and their partner's regarding the
potential capability of stem cells in private and public cord blood banks that are
advertized in many different venues including the internet. A potential disadvantage
would be possible discourse between pregnant women and their partner's due to
differences in the final decision to donate cord blood or not donate. Finally, the worst
disadvantage would be the decision not to donate at all with a possible disadvantage to
their lives should they need it.
Sample Size and Power Analysis
A power calculation determines the needed sample size to detect a particular
effect. Based upon the rule of thumb 15-20 subjects per independent variable,
approximately 45 to 80 participants required to achieve sufficient power. The three
independent variables measured from the questionnaire are: 1) patients' sources of
knowledge about cord blood donation, 2) patients' beliefs about cord blood collection,
storage and use, and 3) patients' knowledge about current indications for cord blood
transplantation.
The power of the test of the null hypothesis is "the probability that it will lead to
the rejection of the null hypothesis" (Cohen, 1988, p.4) and (Munro, 2005, pp. 141-143).
A power of 0.80 means there is an 80% chance of rejecting the null hypothesis. The

higher the desired power, the more subjects required. Cohen suggests that for the
behavioral scientist, a power of 0.80 is reasonable, given no other basis for selecting the
desired level (Munro, 2005, p. 141).
The effect size for the /test is the difference between the means of two groups
divided by the standard deviation for the measure. Cohen's moderate effect size is set at
0.5, which means half of a standard deviation unit. Given an effect size of .70 and a
power of .80 the Cohen table indicates this researcher will need 33 subjects (Cohen,
1988, p.55).
Each time an ANOVA test is conducted one runs the risk of a Type I error
(rejecting a true null hypothesis). The probability level that sets the point at which one
rejects the null hypothesis also is the level of risk with which one is comfortable. When
calculating multiple t-tests on independent samples that are being measured on the same
variable, the rate of error increases exponentially by the number of tests conducted.
Instead of using a series of individual comparisons, we examine the differences among
the groups through an analysis that considers the variation across all groups at once. This
test is the analysis of variance (ANOVA).
Using ANOVA an effect size of .30 (Cohen, 1988, p.355 defines a moderate
effect size as .25, which with two groups is still half of a standard deviation unit) and still
using a power of .80 we would need to have 27 subjects in the group (Munro, 2005,
p. 154; Cohen, 1988, p.384).
However, the researcher will also attempt to use Pearson's correlation coefficient
and when determining the sample size for comparison of two normally distributed
interval variables there are three needed elements as well. They are effect size, alpha, and
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power. Effect size is the absolute value of the difference between the expected correlation
and a correlation of zero. For example, if this researcher expects the correlation to be
-0.4 the effect size would be 0.4. (| -0.4 - 0| = 0.4). The absolute difference is used
because for a sample size calculation it does not matter whether the correlation is positive
or negative. The alpha level is the probability of falsely rejecting the null hypothesis, that
is rejecting the null hypothesis when it is actually true (Type I error). There is no correct
alpha level. The researcher will choose an alpha level based on what is reasonable (Katz,
2006, pp.132 & 135). Most studies accept a 5% chance of rejecting the null hypothesis
when it is really true. Therefore, the researcher will usually specify alpha as 0.05. The
power is the probability of rejecting the null hypothesis if the actual effect is as large as
the estimated effect size. Although this researcher would like a 100% chance of rejecting
the null hypothesis when it is false there is no sure bet this will happen. Usually one
settles for a 0.80 or 0.90 probability (80% to 90% chance) of rejecting the null hypothesis
if it is false (Katz, 2006).
Sample
The research design involves assessment of women who voluntarily want to
inquire about the pros and cons of cord blood donation in the San Diego county area.
Methodology will include use of instruments, or standardized measures, to assess sources
of knowledge about cord blood donation; beliefs about cord blood collection, storage
and use; their knowledge about current indications for cord blood transplantation; This
was measured using the Fox Questionnaire (Fox et al., 2007) and a Readiness for Change
Scale (Prochaska & DiClemente, 1998) titled as the Cord Blood Collection Survey. Basic
demographic information and data concerning age, gestational age, number of children

(parity), marital status, race/ethnicity, religion, highest level of education completed,
economic status, and method of payment for prenatal care was analyzed. The factors
were analyzed in their relationship to women's knowledge level of cord blood collection,
banking and storage (donation).
Because there was a concern about obtaining enough women for the sample size,
several options were explored. A convenience sample was recruited through the
placement of adds in a local newspaper, San Diego Union Tribune, and aflyeravailable
in local church congregations to allow for a convenience sample by volunteering and
non-randomization. There wereflyersin the waiting rooms of two multicultural clinics
where most of the women were of childbearing age. This was the first method at
obtaining participants. The inclusion criteria searches for pregnant women; the majority
of participants were English speaking women even though some were bilingual.
However, there were translators available for Spanish and Arabic translation if needed.
The advantage of the sampling technique was ease in implementation and it was
preferred that a naturally formed group of volunteers participate in the study. The
disadvantage was that this was not randomized to all women. The research procedure
process was available to conveniently include a marginalized population of English and
non-English speaking women; it did not eliminate the possibility of systematic
differences among the participants and the environment of the experiment could have
affected the outcomes. However, the researcher believes this was a representative sample
of women potentially in their childbearing years who were delivering at our hospitals in
the geographical area. The local newspaper advertisement would be read by those women
who are literate, seek an interest in participating in this research, and it was distributed to

a wide net of subscribers as well as availability of the newspaper on the internet. In order
to obtain additional participants this was advertised in local church bulletins. The
researcher included church going women as they are usually family oriented and may be
representative of the pregnant population. To maintain anonymity and confidentiality the
surveys and questionnaires were coded with the individuals last 4 digits of their phone
number. All information was secured by the researcher using password protected files
and locked storage.
Operational Definitions
Dependent Variable: the decision to collect cord blood (1) or not collect cord
blood (0) and it will be to a private bank (1) or public bank (0). This was measured by the
score on the Cold Blood Collection Survey. So the total score of each individual was the
dependent variable.
Dependent variable: Stages of Readiness as described in the transtheoretical
model (TTM) by Prochaska & DiClemente (Prochaska & DiClemente, 1998):
Pre-contemplation (no consideration of changing)
Contemplation (thinking about changing)
Preparation (making plans to change)
Action (actually in the process of changing)
Maintenance (working to prevent relapse)
Independent Variables: The main independent variable (IV) was the patients
identified by their gravida as primigravida OR multigravida. Additional variables which
included: A) Patients' sources of knowledge about cord blood donation; B ) Patients'

beliefs about cord blood collection, storage and use; and C) Patients' knowledge about
current indications for cord blood transplantation.
Demographic Variables or Control Variables for Logistic Regression (these
contain a mix of continuous and categorical variables): age; gestational age in weeks
calculated from last normal menstrual period OR confirmed by 16-20 week ultrasound;
level of parity (number of children); marital status; race/ethnicity; religion; highest level
of education completed; economic status; and method of payment for prenatal care.
Data Collection Procedures with Instruments
Each participant completed a self-administered survey on her first encounter with
the researcher at anytime during the gestation of the pregnancy along with the incentive
that at completion of the survey they would be enrolled in a lottery and be eligible to win
a gift certificate valued at $100. All surveys were cross-sectional, self-administered and
collected by the researcher. The baseline survey includes a staging algorithm designed to
assess individuals' stage of cord blood donation intention, and a second staging algorithm
designed to assess individuals' stage of communicating their cord blood donation
intention with their partner. Staging algorithms were adapted from previous research with
other health behaviors (Prochaska, Velicer, & Rossi, 1994). Wording for these staging
algorithms is presented in Figure 2 in Appendix II. The subject will circle the comment
that most represents the intent of the individual and will circle the comment that most
represents the status of communication with the individual spouse or father of the baby
(FOB).
An explanation of the study was provided followed by obtaining informed written
consent. All women who enter into the study were offered an anonymous questionnaire

to complete. The Fox Questionnaire (Fox et al., 2007) includes multiple choice questions
regarding the sources of information about cord blood, whether they plan to have their
cord blood collected and stored, whether they plan to donate to a. public bank or store
with a private/commercial bank, the reasoning behind these decisions {sources of
knowledge, independent variable 1), the beliefs about the potential uses for cord blood
collected (independent variable 2), and their knowledge about current therapeutic uses of
cord blood transplantation (independent variable 3). The questionnaire was developed to
collect demographic characteristics, (Table 1); Patients' sources of knowledge about cord
blood donation, (Table 2); Patients' beliefs about cord blood collection, storage and use,
(Table 3); and Patients' knowledge about current indications for cord blood
transplantation, (Table 4) (see Appendix I, Tables 1-4). The researcher conducted a faceto-face interview with each participant to establish a positive rapport with them only
before answering the questionnaire. The participants self-administered the survey. No
information was offered at that time regarding education on the differences between
public versus private cord blood donation. Every third participant in the survey was
selected to participate in a one-on-one 60 minute interview using the Interview Guideline
for Cord Blood Donation (see Appendix K). Consent Assent is in Appendix L (see
Appendix L).
Measures
The instrument, Readiness for Change, used for the survey in Table 1 (see
Appendix H), was adapted from a tool in the public domain created by Prochaska and
DiClemente (1982). It is a staging algorithm for readiness to change. This tool has
consistently demonstrated high reliability and validity for general population use, as well
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as with patients with behavior changes, and used quite proficiently throughout the
research community today for studying all types of clinical trial with patients in use of
any type of decision-making process. When doing my literature search the tool came up
262 times on the internet. The tool meets content validity as the items measure the
content they were intended to measure such as the individuals' stage of cord blood
donation intention, and a second staging algorithm designed to assess individuals' stage
of communicating their cord blood donation intention with their partner. This gave a
discrete dichotomous variable on the survey with only two classifications (Yes/No) to
answer the stage of readiness.
The questionnaire used in Table 1, 2,3,4 of Appendix I is adapted from Nathan
Fox (Fox et al, 2007) and for purposes of clarification thistitledthe Fox Questionnaire.
This questionnaire a reflection of categories in age, gestational age, level of parity
(number of children), marital status, race/ethnicity, religion, highest level of education
completed, economic status and method of payment for prenatal care. There was
categorical, nominal, ordinal, interval, and odds ratio scales of measurement. This is the
bases of the descriptive statistics intended to support the results reflective in the
frequency distribution of the mean, median, and mode in each category (see Appendix I,
Table 1). These measures of central tendency will be represented in standard deviations
(sd) of the sample and not the population (SD) to describe the variability. The variability
is the amount by which participants vary or differ from each other. In other words, the
standard deviation, (sd), of the sample will be compared to the population, (SD), in the
literature to examine variability.
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The Fox Questionnaire will also reflect the patients' sources of knowledge about
cord blood donation; patients' beliefs about cord blood collection, storage and use; and
patients' knowledge about current indications for cord blood transplantation. This will
allow one to assess pregnant women regarding their basic understanding of cord blood
donation, beliefs, and knowledge on current indications for transplantation. This will then
be compared to Stages of Readiness placing them in categories of an ordinal scale (see
Appendix J, Table 5). The inferential statistics will allow one to make inferences about
the characteristics of the population from knowledge of the corresponding characteristics
of the sample.
The questionnaire/survey met reliability as the answers were from the individual
without a third party asking the questions for possible bias or misrepresentation unless a
translator was used and this did not occur with this researcher in this population. Content
validity was assessed because the items in the questionnaire/survey where measured on a
scale unique to each individual which is what the questionnaire/survey was intended to
measure. The predictive or concurrent validity was assessed, i.e. that the more
pregnancies one experiences the more knowledgeable one would be regarding cord blood
donation and use. Construct validity was assessed in the questionnaire/survey by the
items which measure hypothetical constructs or concepts regarding pregnant women's
beliefs regarding cord blood collection, storage and use.
Data Management and Analysis
The descriptive statistics will describe the distribution of the independent
variables such as age, gestational age, level of parity (number of children), marital status,
race/ethnicity, religion, highest level of education completed, economic status and

52
method of payment for prenatal care by using measures of central tendency and of
variation. This was done with afrequencydistribution from which the mean, median, and
mode were derived. The computer program in this study used the PASW Statistics
GradPack 18 for Windows®/Mac® (Arbuckle, 2009) on the Fox Questionnaire (see
Appendix I).
The inferential statistics will have multiple analyses using t-test and ANOVA
using PASW Statistics GradPack 18 for Windows®/Mac® (Arbuckle, 2009). To begin the
researcher assessed using a null hypothesis:
Ho= There is no difference in the mean score of Cord Blood Collection (CBC) Survey
fj\ = Pregnant women who speak with their obstetrician
H2 = Pregnant women who do not speak with their obstetrician
^=^1-^2 = 0

By using the t-test one seeks to disprove the null hypothesis with different variable
means: that is, there is no difference between the two means. The t-test is (Katz, 2006,
p. 84) calculated as the difference between the two means divided by the standard error of
that difference:
t=

mean of sample 1 - mean of sample 2
standard error of difference between mean 1 and mean 2
The computer produces the equal (pooled) variance formula and the unequal

(equal variances not assumed or separate) variance formula. Thefirsttask is to look first
at the Levene's test. If the significance level exceeds .05, the equal variance (pooled)
results are used; if the significance level is less than .05, the unequal (separate) variance

results will be used (Munro, 2005, p. 143) and I would reject the null hypothesis (Katz,
2006, p. 85).
Testing the association of a nominal variable with an interval parametric variable
(e.g., the association of ethnicity and Cord Blood Collection Survey score) is similar to
testing the association of a dichotomous variable with the interval parametric variable
(e.g., the association of Cord Blood donation "Yes/No" with the Cord Blood Survey
score). In both situations one will be comparing means. The difference is that with a
nominal variable, there are three or more groups. In such situations, use ANOVA (Katz,
2006, p. 88).
An ANOVA tests the null hypothesis that there is no difference in the means of
different groups; "in other words, any differences between the means are due to random
variation" (Katz, 2006, p. 88) and indicates the probability that the null hypothesis is
correct (Patten, 2007, p. 127). According to the null hypothesis, all groups were from the
same population (a local prenatal care/obstetrical clinic) and each of their scores come
from the same populations of measure (Cord Blood Collection Survey). Any variability
of the scores can be seen in two ways: First, the scores vary from each other in their own
group; this variation is called "within-group variation". Second, the groups vary from
each other; this variation is call "between-group variation". Together, the two types of
variation, prenatal patients characteristics and Cord Blood Collection Score, add up to the
total variation (Munro, 2005, pp. 154-157).
ANOVA produces an F-value. The F-value is the ratio of the between-groups
variance to the within-groups variance (Katz, 2006, p. 88).
F'=

between-groups variance (variance calculated based on entire sample)
within-groups variance (variance calculated separately for each group)
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Because one-way ANOVA calculations are extremely detailed the margin of error
is high and it is easy to make mistakes when doing them by hand. Therefore computer
output is recommended and the researcher here is using PASW Statistics GradPack 18 for
Windows®/Mac® (Arbuckle, 2009), otherwise known as the "new SPSS 18.0". Using this
software the j?-value for F statistic is given. The format shown in table below in Figure
3.1 is the way the one-way ANOVA results were presented.
Source

Degrees of Freedom

Sum of Squares

Mean Square

Between groups

k-1

SSB

MSB

Within groups

nT-k

SSW

MSW

Total

nj-k

SST

Figure 3.1 One way analysis-of variance table format (Shott, 1990, p.151)
Strengths and Limitations ofMethods
If the difference between the means is small or if the error in the measurement of
the difference is large compared to the difference in the means, then the /-value will not
reach statistical significance. The t-test may not be valid for variables with non-normal
distributions. If the mean is not an accurate measurement of the center of the distribution,
then a test based on the comparison of means may not be valid. The t-test is actually a
very robust test because the statistical software is built to take into account situations
when the variance may be unequal. Unequal variance is especially a problem when the
sample sizes are unequal and smaller sample is associated with the larger variance. When
variances are unequal, the researcher will need to perform a t-test for unequal variances
Levene's test is one of the tests to calculate equality of variances. This is in the computer
program where the / value is calculated two ways: assuming equal and unequal variances
(Katz, 2006, p. 85). If the variances are equal then report the value of the t-test assuming
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equal variance. If the variances are unequal report the value of the t-test assuming
unequal variance.
A limitation of the t-test is that it does not give the reader direct information on
the numeric difference between the two groups (Katz, 2006, p. 85). A useful method of
calculating the difference between the two groups is to obtain the mean difference
between the two groups (i.e., mean difference = mean 1 - mean 2) and then take the 95%
confidence interval of that difference (Glantz, 2002, pp.200-9). The difference between
the means would be considered statistically significant if the 95% confidence interval of
that difference excludes zero (Katz, 2006, p. 85).
When performing ANOVA with computer software it can perform one-way
ANOVA calculations but it cannot determine whether independence or normal
assumptions are adhered to in a reliable fashion. This is the responsibility of the
researcher. If the computer is given data that violate assumptions, it will carry out the
analysis anyway which could then be misleading (Shott, 1990, p. 152).
Another important limitation of ANOVA is that it does not indicate where the
difference lies. A large F just tells you that you can reject the null hypothesis that all the
means are the same (Katz, 2006, p. 89). For example, if the researcher compares three
groups A, B, and C, there are a total of seven possible ways that the groups may differ
from one another (Katz, 2006, p.89):
A is different than B (but not different than C)
A is different that C (but not different than B)
B is different that C (but not different than A)
A is different from both B and C (which are not different from one another)

B is different from both A and C (which are not different from one another)
C is different from both A and B (which are not different from one another)
A and B and C are all different from one another
To see where the differences lie, it is necessary to perform pairwise comparisons
of the groups using a t-test. "The important difference is that when you use the t-test for
pairwise comparisons you are performing multiple comparisons. When making multiple
comparisons you should set more stringent criteria (i.e., a lower P-value) before rejecting
the null hypothesis" (Katz, 2006, p.90). This is to prevent a Type I error.
There are several important issues related to the use of statistical analysis using t-test and
analysis of variance. First, there is the issue of the ratio of participants to variables
included in the analysis. Problems may occur if too few participants relative to the
number of predictor variables exist in the data (Mertler, 2005). Also, post-hoc
comparisons with ANOVA can be a problem as well.
Human Subjects
Risks and Benefits
Participation in research may involve risks or discomforts. Potential risks and
benefits were disclosed in the informed consent (see Appendix L). Although this is
strictly a descriptive correlational study, completion of the questionnaires may cause
participants to experience anxiety, or discomfort and possible discourse with their
significant other. To avoid this, the questionnaires were administered in a private setting
within the university where the participant can answer without fear of interruption from
family or other personnel. The participants were instructed that they need not answer any
question they wished to omit. After the woman hasfinished,the participant will place the
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completed questionnaires in an envelope that is labeled with a unique patient identifier,
known only to the investigator. The participant will seal the envelope and give it to the
researcher who will analyze the results at a later time in a private setting.
There may be no direct benefit from participation in this study. However, several
possible benefits exist. One possible benefit is early identification of level of knowledge
which will alert the individual mother of concerns regarding her possible selection to
cord blood use and preparation for the birth of her child and her expectations. This gives
her an opportunity to decide if she chooses to discuss with her significant other the pros
and cons of different types of cord blood collection for use. This will allow her to see if
she is ready to even make a decision regarding this important issue and what she may
need to do to get the information to complete a well informed decision regarding cord
blood use. All of these interventions may inform and improve the participant's health
status and family preparation for future years to come.
Protecting subjects from any potential risks
To minimize potential risks the participants were volunteers and there was no
coercion of any type used. If there is a question that she desires not to answer on the
questionnaires she will not be eliminatedfromthe study. If she desires more information
regarding this issue after answering the questionnaires, the researcher will give written
handouts explaining the information. This will not be distributed beforehand as the
researcher desires to get nonbiased information in the beginning. If there is discourse
between couples around this subject, a counseling service was provided for the couple as
social support per their request (see consent form Appendix L and see recruitment flyer
Appendix M). There was a Spanish translation of the Flyer, Consent, Readiness Scale,

Fox Questionnaire and Interview Questions done by a paid and certified linguistic
assistant at a local university working towards a degree to be a psychologist in a dual
track of curriculum in the College of Sciences & Engineering and the College of Arts and
Letters.

Chapter IV
Data Analysis
The purpose of this study is to investigate pregnant women's knowledge of cord
blood collection issues and what decision-making process and complexities they undergo
regarding or in conjunction with cord blood donation at the birth of their infant. The
survey assessment items were selectedfromthe Fox Questionnaire and patient's
identification of the stage of readiness in their decision regarding cord blood collection
for donation at the time of the study. The research question: What characteristics
during a woman's pregnancy are related when making a decision for cord blood
donation at birth?
The following hypotheses tested and are listed below:
Hypotheses:
1) Women are not knowledgeable of their options to store infant's cord blood
(CB) with a storage bank for possible future use by the child or other family members.
The researcher is interested in examining whether the variables of age, gestational
age, level of parity (number of children), marital status, race/ethnicity, religion, highest
level of education completed, economic status and method of payment for prenatal care
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are related to knowledge of cord blood donation. First, a descriptive profile of the sample
was presented, followed by the results specific to the research questions.
The same principles in the Transtheoretical Model can be used for pregnant
women learning about cord blood collection, banking, and storage of her infant's blood at
the time of birth. If she has asked for assistance in understanding the process, we could
presume that she is past the pre-contemplation stage. However, if she is seeking
information to make a decision regarding public or private banking she may be further in
the stages of readiness to change through preparation (making plans to change) or action
(actually in the process of changing) thus making a decision. A Stage of Readiness Scale
was used and adapted from Prochaska et al. (Prochaska, Velicer, & Rossi, 1994; Quinn,
Alexander, Hollingsworth, O'Connor, & Meltzer, 1994) (see Appendix H, Figure 2).
The responses to the survey pertaining to the participants and the spouses'
partners are stages of readiness: pre-contemplation; contemplation; preparation; action;
and maintenance are presented in Table 4. The majority of women and their partners
(52%) responded that they are in the pre-contemplation stage. Table 4.1 below reflects
the outcome of the Stages of Readiness on the Stages of Readiness Scale.
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Table 4.1 Stages of Readiness Scale
Stage
*

Pre„ , „.
Contemplation
Preparation Action
r
contemplation

Maintenance Total

JZntion

15(50%)

9(30%)

4(13%)

2(7%)

0(0%)

30
(100%)

16(53%)

6(20%)

3(10%)

3(10%) 2(7%)

30
(100%)

31(52%)

15(25%)

7(12%)

5(8%)

60
(100%)

Women's

faTmei
Notification
Total

2(3%)

Table 4.2 Comparing Gravida with Stages of Readiness Scale
Gravida

PreContemplation Preparation Action
contemplation

Maintenance Total

Primigravida 7(47%)

4(27%)

3(20%)

1(7%)

0(0%)

15
(50%)

Multigravida 8 (53%)

5 (33%)

1(7%)

1(7%)

0(0%)

15
(50%)

Total

9 (30%)

4(13%)

2(7%)

0(0%)

15 (50%)

30

(100%)

Women have not given any thought to being a cord blood donor 50% of the time
while 30% are giving some thought to being a cord blood donor weighing the pros and
cons, 13% are preparing to be a cord blood donor, 7 % have signed consent and not
spoken with their spouse/partner. Given the distribution of responses, this variable was
transformed into a dichotomous response of 1) no thought regarding cord blood donation
and 2) thinking about cord blood donation for further analysis.
The analysis of the Readiness Scale was adjusted for parity (number of children
born). Table 4.2 demonstrates that women (86%) with more than one child
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(multigravidas) were in the Pre-contemplation (53%) and Contemplation (33%) stage
compared to women (74%) having their first child (primigravida) with 47% in the Precontemplation stage followed by 27% in the Contemplation stage respectively; however
more of those women who were primigravidas were in the Preparation Stage 20% of the
time when it is time to decide on cord blood donation. This means they are preparing to
be a cord blood donor and learning more about their consent options. They are moving
further along the path to a decision they wish to make for their family regarding donation
of cord blood.
Sample Characteristics
The dataset contains all responses from 30 completed questionnaires from the 35
which were distributed through volunteer encounters over an 11 month period, August
2009 to June 2010. This was a response rate of 86%. None of the participants had made a
decision to collect cord blood at the time of the questionnaire. The demographics of the
study participants are listed in Table 4.3.
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Table 4.3 Demographic Characteristics of Study Participants

Age (years)

14-45

Mean
(Standard Deviation)
26

Gestational Age (weeks)

16-40

24

Table 4.3 b

Group
None
1 or more

N(%)
15 (50%)
15 (50%)

Marital Status

Single
Married

18(60%)
12 (40%)

Race

Hispanic
Caucasian
Other

17 (57%)
7 (23%)
6 (20%)

Religion

Christian
Catholic
Other

4 (13%)
11(37%)
15 (50%)

U u <i i rj,j
,
Highest level of Education

HS Diploma
^
^ Hg ^

16(53%)
^ ^?%)

Total Household Income/yr.

Less than $50,000
Greater than $50,000

24 (80%)
6 (20%)

Method of Payment for
Prenatal Care

Self-Pay
Insurance
Medi-Cal

1 (3%)
5(1%)
24 (80%)

Discuss CBC w/ OB/CNM?

Yes
No

9 (30%)
21 (70%)

If not, do you plan to discuss
CBC w/OB/CNM?

Yes
No

14 (47%)
16 (53%)

Table 4.3a

Number of Living Children

Range

^
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Overall, the participants had a minimal education level of a high school education
(53%) but 14 (47%) had either completed or entered an undergraduate university. Of
these, 4 (28.5%) entered and completed a postgraduate degree. This may be attributed to
the severe economic recession in the USA, December 2007 to June 2009. The fact that so
many women with an advanced age were seen at a community clinic can be attributed to
this too. San Diego, which is considered a service economy, sustained official
unemployment rates greater than 10% during this time period (Bureau of Labor Statistics,
2010) and many of the employed and under employed lost health insurance coverage.
The participants age ranged from 14 to 45 years of age and gestational age were
evenly distributed from 16 weeks to 40 weeks. There were two groups that clustered at 23
weeks and 33 weeks. The majority of the sample (57%) was Hispanic (17) which
reflected the clinics location as a predominantly Hispanic area in San Diego which has
grown during the last 20 years. The remaining component reflected the areas diversity:
23% Caucasian (7), 20% Other (6) of which broke down specifically to: (1) Asian/Pacific
Islander, (2) Black, (2) Iraqi, and (1) other. Since 2000 there have been economic
struggles for many families and there an estimate of 2,000 people who used Arabic as
their main language who migrated to San Diego from Iraq, Jordan, Lebanon, and other
countries of the Middle East (Coalition, 2010). San Diego is the largest metropolitan area
west of Detroit, Michigan which houses more than 80,000 members of the Middle
Eastern population in the last 4 years (Coalition, 2010). However, because my sample
was small this may not have influenced this at the time but may if future study leads to a
large sample of the population.
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The predominant religious groups were 13% Christian (4), Catholic 37% (11) and
Other as 50% (15). Many included the description for being Caldean and "not Catholic"
by preferring to be identified as the option of Other.
Method of payment for prenatal care was predominantly in one of three groups.
Self-pay 3% (1), Insurance 17% (5), andMedi-Cal (California Medicaid) which was 80%
or (24).
*The null hypothesis: "There is no difference in the CBC (Cord Blood Collection)
Score if one had talked with their obstetrician/CNM OR had not talked with their
Obstetrician/CNM. AND, if they had not talked, did they plan to talk with them. The
CBC Score was calculated on a scale of 10 questions. The higher the number out of 10
the higher the subject scored the more perfect the total score. A t-test for independent
means compared for two samples that were independent of each other. This method
{independent) is used to indicate there is no relationship (no matching or pairing) of
scores from one sample to the other. The selection of individuals for the groups had no
bearing on the selection of individuals for the control group, the two samples were said to
be independent. In other words, they were separately and independently drawn from the
population of participants.
When measuring the CBC Score with the t-test for independent means on two
categories of age: the mean for Group 1 (Less than 24 years of age) and Group 2 (24
years of age or more) the mean for Group 1 {m = 2.26, sd = 2.49) is lower than the mean
for Group 2 (m = 3.13, sd= 2.94) at the .194 level (/ = -.869, df= 27.2). Because the
variances were different, a t-test that did not assume equality of variances conducted with
a confidence interval (CI) = .95. Therefore, there is no significant difference.

When measuring the CBC Score with the /-test for independent means for two
categories number of living children: the mean for Group 1 (No living children) and
Group 2 (1 or more living children) the mean for Group 1 {m = 2.3, sd = 2.46) is lower
than Group 2 (m = 3.06, sd = 2.9) at the . 143 level (/ = -.733, sd = 27.0). Because the
variances were different, a t-test that did not assume equality of variance conducted with
a confidence interval (CI) = .95. Therefore, there is no significant difference.
When measuring the CBC Score to Race using a One Way ANOVA for more
than two means, there yields a value of F at 6.423 and the associated probability of .005.
The difference among the means can be declared significant at the .01 level. For the
Hispanic group, the mean reported CBC score level was 2.0 {sd =2.4). The mean reported
CBC Score level for the Caucasian group was 5.4 {sd = 1.9) and the mean reported CBC
score level for the Other group was 1.5 {sd= 2.3), respectively. The differences among
the means are statistically significant at the .01 level (F [2,27] = 6.423).
When measuring the CBC Score with Payment Method using a One WAY
ANOVA measuring the difference between and among self-pay group, private insurance
group, and Medi-Cal insurance group there yields F at 3.344 and the associated
probability of .050. The difference among the payment methods and CBC score is
significant at the .05 level. For the self-pay, the mean reported CBC Score .000 {sd =
N/A). The mean reported CBC Score for private insurance was 5.2 (sd- 2.167) and the
mean for the Medi-Cal insurance and CBC score was 2.3 {sd- 2.5) respectively. The
difference among and between the means is significant at the .05 level.

When measuring the CBC Score with the participant answer to: Did you discuss
CBC with your OB/CNM? If not, do you plan to discuss CBC with your
Obstetrician/CNM? The following measured:
The "Sig" for "Levene's Test for Equality of Variances" is .002. Because .002 is
less than .05, it is not appropriate to assume equality of variances.
The mean for Group 1 {m = 1.43, sd = 1.83) is significantly lower than the mean
for Group 2 (m = 3.18, sd= 2.93) at the .05 level (/ = -2.7, df= 25.5). Because the
variances were significantly different, a / test that did not assume equality of variances
was conducted. Table 4.4 is the synopses of the data.

Table 4.4 Response to Cord Blood Collection Survey by Demographic Factors

Test

Critical
Value

P-value

Age

/test

-0.869

0.39

NS

Gestational Age

/test

-0.081

0.94

NS

Number of Living Children

/test

-0.733

0.47

NS

Marital Status

/test

0.054

0.957

NS

Race

ANOVA

6.423

0.01

*

Religion

ANOVA

0.19

0.83

NS

Highest Level of Education

/test

0.24

0.81

NS

Total Household
Income/yr.

/test

-1.69

0.1

NS

Method of Payment for
Prenatal Care

m

m

A

3J44

1.29

Q0$

Discuss CBC w/OB/CNM

/test

0.2

NS

If no, do you plan to
discuss w/OB/CNM?

ttGSl

~Zn

UUD

Would it make a difference
in a decision to CBC if you
knew your OB/CNM paid a
fee?

/test
ANOVA

-0.04
0.001

0.97
0.1

NS
NS

The chance that my baby
would have a conditionfat
A^T^TA
,. ,
. , T ^ .
, , ANOVA
birth or in the future)
could
be used

^ ^^
2.252

n m<r
0.106

T,™

The chance that a sibling
who is healthy would
develop a condition that
could benefit from CBC

Ai\~k

0.01

*„

AMOVA

NS

For most conditions
requiring cord blood
therapy, could a child use
cord bloodfrom his/her
own placenta?

ANOVA

0.64

0.64

NS

For most conditions
requiring cord blood
therapy, could a child use
cord blood from a sibling's
placenta?

ANOVA

0.82

0.55

NS

If your child did need cord
blood therapy and you did
not have cord blood stored
from him/her or a sibling,
ANOVA
what is the chance cord
blood from a public storage
bank could be used?

0.59

0.71

NS

Do San Diego hospitals
have a system in place
whereby you could donate
the cord blood to a public
cord bank?

ANOVA

0.85

0.48

NS

Age

Chi Square x2

3.75

0.053

**(>.05)

Gestational Age

Chi Square x2

9.6

0.002

* (>.001)

*P= @ the .01 level comparing CBC with Race
**P= @ the .05 level comparing CBC score with Payment Method
***P= .014/.012 are unequal and slightly above the .01 level therefore needs to be at the
.05 level comparing the CBC score and "If one has not discussed CBC with your
OB/CNM, do you plan to discuss with your OB/CNM?

70
Sources of Women's Knowledge
The main sources of the participant's knowledge came from seeing/reading ads in
magazines/commercials regarding cord blood storage 53% of the time but only 37% read
or saw literature related to private banking versus 20% on public banking. Table 4.5
reflects some other ways like discussing cord blood donation with their obstetrician or
midwife. This was taken from the Cord Blood Collection Survey Table 2 on page 24 of
the questionnaire.
Table 4.5 Sources of Knowledge
Yes

No

Total

Discussed CBC
w/OB/CNM.

9 (30%)

21 (70%)

30 (100%)

If no, do you plan
to discuss w/OB/CNM.

14 (47%)

16 (53%)

30 (100%)

11(37%)

19 (63%)

30 (100%)

16 (53%)

14 (47%)

30 (100%)

6 (20%)

24(80%)

30 (100%)

Seen/read literature
distributed by
private/commercial
CBC companies
regarding cord blood
storage.

Seen/read ads in
magazines/commercials
regarding cord blood
storage.

Seen/read literature
distributed by a public
cord blood bank
regarding cord blood
donation.
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Women's Belief about Cord Blood Collection, Storage, and Use
Table 4.6 Women's Beliefs about Cord Blood Collection, Storage, and Use for
Transplantation
F2
Would it make a difference in a decision to store cord blood
with a private/commercial cord blood bank if you knew that
your OB would be paid a fee to collect the cord blood?

YES=5
NO=16*
N/A=9

F3
The chance that my baby would have a condition (at birth or
in the future) that could benefit from cord blood during
his/her first 10 years of life is about:

1 in 100=4
1 in 1000=6
lin 10,000=7
<1 in 10,000=1
N/A=12*

F4
The chance that a sibling who is now healthy would develop
a condition that could benefit from this cord blood is about:

1 in 100=4
1 in 1000=6
1 in 10,000=6
<1 in 10,000 =1
N/A=13*

F5
For most conditions requiring cord blood therapy, could a
child use cord bloodfrom his/her own placenta?

Always=7
Usually=8*
Sometimes=6
Rarely=4
Never=0
N/A=5

F6
For most conditions requiring cord blood therapy, cold a
child use cord blood from a sibling's placenta?

Always=l
Usually=6
Sometimes=ll*
Rarely=l
Never=3
N/A=8

F7
If your child did need cord blood therapy and you did not
have cord blood stored from him/her or a sibling, what is the
chance cord bloodfrom a public storage bank could be
used?

Always=3
Usually=3
Sometimes=7
Rarely=10*
Never=2
N/A=5

F8
Do San Diego hospitals have a system in place whereby you
could donate the cord blood to a public cord blood bank?

YES=6
NO=4
Don't know=19*
N/A=l
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When one assesses and compares the Women's Belief Model about Cord Blood
Collection, Storage and Use there are numerous beliefs participants shared on the survey.
The majority 49% (16) answered "NO" followed by 30% (9) as not applicable when
answering the question, "Would it make any difference in a decision to store cord blood
with a private/commercial cord blood bank if you knew that your OB would be paid a fee
to collect the cord blood?"
When asked, "If there a chance that my baby would have a condition (at birth or
in the future) that could benefit from cord blood during his/her first 10 years of life...."
40% answered "not applicable" with the second most frequent answer being 1: 10,000 at
23%. Another belief expressing the chance that a sibling who is now healthy would
develop a condition that could benefit from this child's cord blood also answered 43% of
the time as "not applicable" (13) and the second most frequent answer 1:10,000 (6) or
20% of the time.
The belief, "For most conditions requiring cord blood therapy, could a child use
cord blood from his/her own placenta?" was answered as "usually" (8) 27% of the time
compared to always (7) 23%, sometimes (6) 20%, rarely (4) 13%, never (0) 0% and "not
applicable (5) 17% of the time. Another belief, "For most conditions requiring cord blood
therapy, could a child use cord blood from a sibling's placenta?" answered most
frequently as sometimes (11) 37% followed by not applicable (8) 27%, usually (6) 20%,
never 3 (10%), always (1) 3%, and rarely (1) 3% of the time respectively.
"If your child did need cord blood therapy and you did not have cord blood stored
from him/her or a sibling, what is the chance cord bloodfroma public storage bank could
be used?" mostfrequentlyanswered rarely (10) 33%, followed in descending order as
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sometimes (7) 23%, not applicable (5) 17%, always (3), 10%, usually (3) 10%, and
finally never (2) 7% in that descending order. Another way to look at this would be to
imply that (13) or 43% had a positive understanding or belief that a public bank could
help them but (17) or 57% did not believe a public bank could help them.
The last belief the participants answered was, "Do San Diego hospitals have a
system in place whereby you could donate the cord blood to a public cord blood bank?",
and the majority (19) 63% answered they did not know followed by (6) 20% who said
yes on the survey, and (4) 13% who said no on the survey with (1) 3% answering not
applicable. This is most likely true as there is clearly not a system set in place to educate
the public where to obtain public banking in the San Diego municipal area. Even if you
are highly educated in this group it seemed to still be a barrier for one tofindthe
information expressed by one participant when being interviewed and she had a higher
level of education with a degree as a doctor in philosophy.

Chapter V
Discussion ofFindings
The Nation's labor markets were deeply affected by the deteriorating economic
conditions that began December 2007 and continued for the next two years. Some have
referred to this period as the "Great Recession" of 2007-2009 (Sum & Khatiwada, 2010).
The National Bureau of Economic Research, the Nation's arbiter of the beginning and
ending dates of recessions, has designated the recent recession as having lasted from
December 2007 to June 2009.
Because of the recession, 2009 was one of the worst years for poverty in America
in more than half a century. The total number of Americans living in poverty hit 43.6
million, the highest level in 51 years and the national poverty rate rose to 14.3 percent
from 13.2 percent, according to data released late 2010 by the Census Bureau (NCB,
2010; Huffington, 2010). One in seven Americans is living in poverty at the time of this
writing per. Mint, the personal finance site, put together an interactive chart of regional
poverty rates (Mint, 2010) and California's percent of poverty levels range from less than
10%upto25%-30%.
Though suburban areas are now home to one-third of America's poor, large cities
have not been immune to the after math of the recession (Huffington, 2010; Mint, 2010)
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(NCB, 2010). Residents of cities like San Diego have seen some of the biggest drops in
personal income in the last year. Crippling poverty rates in many of America's hardest-hit
regions have been accompanied by several other disturbing trends for the middle class.
Income inequality hit an all-time high before the recession, according to the University of
California, Berkley, economist Emmanuel Saez (Huffington, 2010). States, faced with an
estimated budget shortfall of $380 Billion for 2011 (Huffington, 2010; NCB, 2010;
Coalition, 2010) have started to cut crucial services and have allowed thousands of
workers to be jobless.
Growing layoffs last year caused millions of Americans to lose employeeprovided health insurance, leaving 16.7 % of Americans with no health insurance, the
highest level since the United States Census started collecting the data in 1987
(Huffington, 2010). The ranks of discouraged workers and others marginally attached to
the labor force also had increased during this recession 2007 to 2009. These individuals
are those who wanted and were available for work and had looked for a job sometime in
the prior 12 months. They were not counted as unemployed because they had not actively
searched for work in the past 4 weeks. The number of persons who were marginally
attached to the labor force increased sharply during the current recession, rising to 2.1
million in the first quarter of 2009 (Bureau of Labor Statistics, 2009 & 2010).
The unemployment rate in the San Diego County was 10.2 % in October 2010,
and below the October 2009 estimate of 10.6%. This compares with an unadjusted
unemployment rate of 12.0% for California and 9.0 % for the nation during the same
period (National Bureau of Labor Statistics, 2010). This was during the time the data
collection took place in San Diego.
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Patient Profile
The local clinic has been providing services and programs available to all lowincome residents in the community it serves since 1990 and it celebrated the Twenty Year
Anniversary in 2010. Many of the patients were immigrants and refugees, many of whom
were in the country legally and were forced to leave their native countries due to conflict
or other upheaval as civil war and ethnic cleansing occurred. The clinic placed a high
value on the support of the family and provided comprehensive programs that strengthen
both the children and adults. Some patients were second or third generation families from
the communities they serve. Most were struggling to survive initially when entering the
United States but are now learning to build their knowledge of the community and its
resources to become more self-sufficient and they all rely on the clinic not only for health
care but for their non-medical needs as well.
One of the local clinics, part of the Central Region of San Diego, is a federally
designated MUA/MUP-Medically Underserved Area/Medically Underserved Population.
The primary service area has a population of 199,230 which is a small part of a larger
extended area that includes the entire Central Region of San Diego County with a
population of approximately 488,205. The community clinics data characteristics are as
follows: 64% are women (83% of those are of childbearing age). Ninety-six percent
(96%) are non-white and 80% say they prefer to be served in a language other than
English. An astounding 98% of them are below the Federal definition of poverty (double
that of all of San Diego County, the state of California and the United States as a whole).
The vast majority (92%) are either uninsured or rely on public insurance programs for
partial coverage (La Maestra Community Health Centers, 2007). The location in the
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community serves as a mesh of inner city challenges of poverty, unemployment, and poor
access to health care or social services. Linguistic and cultural barriers compound these
problems. The need for translators to be provided to health care workers caring for this
population has been challenged as there are over 37 separate census tracts served by this
overburden facility on Fairmount Avenue (La Maestra Community Health Centers,
2007). There are no "County Hospitals" in San Diego. This region of the city has a
19.22% poverty rate (Mint, 2010; Bureau of Labor Statistics, 2010; La Maestra
Community Health Centers, 2007), highest teen birth rate, lowest prenatal care utilization
rates, lowest health insurance coverage rates, and highest rate of reported child abuse.
El Cajon was the second area of data collection in the East San Diego County. It
is a more rural desert setting and experiences similar problems to those of City Heights.
In El Cajon, the majority of the population is Latino although "official" census numbers
report only 26%. This was witnessed by this researcher working as a nurse practitioner
and midwife over the last two to two and one-half years when she wimessed the majority
of the patients coming to the clinic suddenly changed from Latino to populations from
Iraq and other Middle East Countries with Arabic as their main language. Because of the
high cost of housing in coastal areas, there is a migration of middle income, working
people buying homes in El Cajon and commuting west. From outward appearances
household incomes seem to be increasing but this development masks the fact that there
is still high local unemployment, underemployment, and poverty. Many Hispanic
refugees and Chaldean immigrants, who escaped from Iraq, live in El Cajon and struggle
with linguistic and cultural barriers that continue to exist. There are 29 different census

tracts with a total population of 118,902 (according to the 2002 census). All of the East
Region of San Diego County has a population of approximately 446,750.
In both of the clinics there is a high use of translators/interpreters due to the
limited English proficient (LEP) skills of many patients. An estimated 50 million people
in the United States do not speak the same language as their healthcare provider, and 23
million are considered LEP (Rousos, Mueller, Hill, Sala, Hovell, & Villarreal, 2010).
This was particularly apparent with the women who present with Arabic as their main
language. They preferred female translators over male translators a vast majority of the
time. The attention to the role of gender during interpreted medical visits is important to
improving health care and health for persons with LEP. At both climes it is a common
practice to minimize use of family members or friends for translation due to
confidentiality and use bilingual staff members or professional interpreters. This was
mandated by Federal Civil Rights legislation since 1964 where language assistance
services became available free of charge for all LEP patients at all points of health care
(Chen, Youdelmanm, & Brooks, 2007). Although the research is very limited in the use
of gender with LEP patients it is hopeful that the influence of the interpreter on providerpatient communication is likely to reduce the disparities in the medical outcomes across
chronic and acute illnesses (Rousos, Mueller, Hill, Sala, Hovell, & Villarreal, 2010).
Cord blood is a noncontroversial source of stem cells, yet experts estimate that
99% (Rochman, 2010), of this potentially lifesaving resource gets thrown away in the
postpartum period. One may believe from this study that it is due to so many barriers
present to them around concerns of communication and the options of how to ascertain
the information. Unlike the stem cells in human embryos, which can morph into any kind

of cell in the body, the stem cells in cord blood have their futures largely mapped out
(Powell, Hingorani, & Kolb, 2009) as blood, brain, liver or heart muscle cells for
example. But researchers have shown that cord blood cells can be reprogrammed, and
over the next decade, doctors hope to adapt these cells to treat heart attacks, strokes,
diabetes and maybe neurodegenerative diseases too. An interview by Bonnie Rochman
with Dr. Joanne Kurtzberg, director of the Carolinas Cord Blood Bank at Duke
University (Rochman, 2010) she states: "Cord blood is already being used in therapy
regimens for patients with cancer, sickle-cell anemia, immunodeficiency, marrow failure
and genetic diseases that call for transplants". As their due date creeps closer, many
pregnant women pack a "go bag" for the hospital: toothbrush, personal music selections
to listen when in labor, cute outfit to dress baby in when coming home. Over the last few
years savvy mothers-to-be have started tucking in one more important item: a kit to
collect and donate the blood in their babies' umbilical cord. This is only accessible for the
woman who can afford such a high price of $2,000-$3,000 for the kit to complete the
initial processing and approximately $125 to $250 per year after that to store cord blood
that can be used only by the donor's family when donating to a private bank. Or, if it is a
public bank, by contrast, one can make their contents available to anyone who is a close
enough match at no cost or fee.
The question this researcher posed to the marginalized population in this study:
Do women know that this form of stem cell therapy is available through cord blood
collection at the birth of their infant? And, if they do, can they have a choice of cord
blood storage through knowing the difference between a private or public bank living in
San Diego County? Of note was 70% of the women had not discussed cord blood
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donation with their provider and of those, 47% planned to discuss it with their OB/CNM.
This brings this researcher to the conclusion they were curious and had a plan in mind. At
what level of readiness where they at the time of the survey? Women's intention was in
the Pre-contemplation Stage 50% and Contemplation Stage 30% of thetime.That means
80% of the population studied were ready to act on the information they had learned from
at the time of the survey. Women's Spouse/Partner Notification pre-dominantly in the
Pre-contemplation Stage 53% of the time followed by the Contemplation Stage 20% of
the time.
When one compares gravida with stages of readiness scale one may speculate that
the more pregnancies one has the more likely they are to be more in the stages of
readiness such as preparation and action. What data illustrated 7 (47%) of Primigravida
and 8 (53%) of Multigravida group were in the Pre-contemplation Stage and the rest were
in the Contemplation 4 (27%0, 5 (33%), Preparation Stage 3 (20%), 1 (7%) and Action
Stage 1 (7%), 1 (7 %) respectively between Primigravida and Multigravidas. Their
sources of knowledge camefromseeing/reading ads in magazines/commercials regarding
cord blood storage 53% of the time but only 37% read or saw literature related to private
banking versus public banking 20% of the time respectively.
When looking and comparing the women's beliefs about Cord Blood Collection,
Storage, and Use most of the women answered "not applicable" to their belief questions
because I believe they truly did not know. They answered "usually" for most conditions
requiring cord blood therapy when the child could use his/her own cord blood from the
placenta. The likelihood of this occurring has been proven in the scientific journals
(American Academy of Pediatrics, 2007, pp. 165-170) and range from less than 1 in 1,000
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to more than 1 in 200,000 (Johnson, 1997). No accurate estimates exist of the likelihood
of children to need their own stored cord blood stem cells in the future (American
Academy of Pediatrics, 2007, pp. 165-170). They also answered "sometimes" cord blood
can be usedfromtheir siblings placenta, which is more often the case. There is only a
25% chance for identifying a full HLA match in a sibling donor (Karanes, Confer,
Walker, Askren, & Keller, 2003; Wagner, 1996). The question related to the belief: "If
your child did need cord blood therapy and you did not have cord blood stored from
him/her or a sibling, what is the chance cord blood from a public storage bank could be
used", was answered "rarely" when the literature clearly states there is a high probability
in a public bank this can be found. There are more than seven million potential unrelated
volunteer adult donors registered in the National Marrow Donor Program registry
(Karanes, Confer, Walker, Askren, & Keller, 2003) and there are many patients unable to
find a fully matched donor, which diminishes access to transplantation therapy. Nonwhite
patients have a lower chance of identifying a fully matched unrelated adult donor because
of genetic heterogeneity and lack of non-white donors. However, over the last decade,
unrelated-donor, banked umbilical cord blood has been shown to contain sufficient
numbers of stem cells for successful transplantation between unrelated, partially HLSmismatched individuals (Kurtzberg, Laughlin, Graham, et al., 1996; Rubinstein, Carrier,
& Scaradavou, 1998; Rocha, Wagner, Sobocinski, et al., 2000; Gluckman, Broxmeyer,
Auerbach, et al., 1989; Migliaccio, Adamson, Stevens, Dobrila, Carrier, & Rubenstein,
2000). This means with the advances in the clinical practice of cord blood
transplantation, most patients unable to find a fully matched adult donor can identify a
partially matched cord blood donor. Thefinalquestion: "Do San Diego hospitals have a
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system in place whereby you could donate the cord blood to a public cord blood bank?"
was answered by most of the participants as "don't know" and they don't know because
there is little advertising in this area. The area is predominantly taken over by the forprofit cord blood banks. They learned that San Diego does not offer public banking
because they have no such bank in this geographic area based on the interviews done on
11 of the participants whom were interviewed.
Shared decision making should be the commonly used process, requiring shared
information among relevant care providers and a willingness and capability to
communicate effectively with parents. This process also suggests the need for outcome
data. Such data should be relevant to the population seeking care at a given institution.
Relying on national or other reported regional or institutional data from outside a
particular practice setting is not always valid, because data from different practice
settings likely are neither constituted nor controlled in the same fashion. The provision of
care, which is decided by local clinical and population data and the determination of best
interests, or what can be viewed as effective, beneficial, and appropriate care versus
ineffective, burdensome or inappropriate care, demand the availability of data from
which to make these determinations with parents (Carter, 2009). Until such data are
available, healthcare professionals should be frank in recognizing and communicating
some uncertainty in their decisional process with parents. Conversely, although objective
outcome data are important, for any given baby and their parents, the chance of a certain
outcome is either 0 or 100% in their minds. Thus, discussions of relative risks, while
useful for healthcare professionals may not be particularly helpful when discussing
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treatment options, risks, and benefits with parents and other family members (Carter,
2009).
Why does one even care or have concern about how one gets hematopoietic stem
cells transplanted from cord blood or sometimes called placental blood versus bone
marrow?
Stem cells are self-renewing cells defined by two properties: (1) they can proliferate to
make differentiated cell types of a tissue in vivo, and, once developed, (2) they can
continue to self-renew for the lifetime of the organism. Presently the only stem cell of
clinical relevance is the hematopoietic stem cell, which can reconstitute the blood system
after bone marrow transplantation (Nussabaum, Mclnnes, Willard, & & Boerkoel, 2001).
Although bone marrow has long been the major source of transplantable
hematopoietic stem cells and progenitor cells, the discovery that placental blood OR cord
blood represents a rich source of hematopoietic stem cells is beginning to make a
substantial impact on the treatment of malignancy and genetic diseases.
The use of cord blood has three great advantages over bone marrow as a source of
hematopoietic stem cells. First, recipients are more tolerant with incompatible cord blood
than of other allogeneic (other) donor cells. Thus, engraftment occurs even if as many as
three HLA antigens are mismatched between the donor and the recipient. Second, the
wide availability of cord blood, together with the increased tolerance of incompatible
donor cells, greatly expands the number of potential donors for any recipient. The latter
feature is of particular significance to patientsfromminority ethnic groups, for whom the
pool of potential donors is relatively small. Third, the risk of graft-versus-host disease is
substantially reduced using cord blood cells as the donor source. It is likely that the
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isolation and characterization of stem cells from other tissues, including nervous system,
will eventually make cell replacement feasible in a wide variety of malignancies and
genetic diseases; (Arora et al., 2009; Hansen et al, 1998; Moore, 2010; Gutman et al.,
2009; Kataoka et al., 2008; Koh, 2004).
Nursing Implications
The American Medical Association and the American Academy of Pediatrics
recommends public banking over private, favoring private banking only when there is
already an affected family member or a disease in the family that would benefit from a
transplant. Many consumer cord blood banking organizations do not support one type of
banking over another but recommend that parents be informed of the pros and cons of the
various options (Besser, Schwartz, Romo, & Salahi, 2010).
According to Frances Verter, founder and director of the nonprofit organization,
Parent's Guide to Cord Blood Foundation, the overall benefits outweigh the chance it
may never be used. And, because there are only 17 public banks in the U.S. that tend to
collect units from nearby hospitals, many families may not be in an area where public
bank donation is as accessible. That makes it more difficult for many parents to
understand their options when it comes to choosing between public and private banking.
There is a problem in that there are a limited number of places that accept donations. The
downside is that lots of parents want to donate, but it requires money to process the
donation. There's a certain infrastructure involved that not a lot of centers have in place.
Furthermore in the report it goes on to say, according to Chris Ober, co-founder of Save
the Cord Foundation, besides the limited number of public banks available for parents to
choose, it is often difficult to distinguish between the various options that individual
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private companies offer. Everything looks great on the Internet, but there are great
differences between all of the private banks. One really needs to do your homework to
make sure the bank you choose is right for you (Besser, Schwartz, Romo, & Salahi,
2010).
Cord blood donation should be discouraged when cord blood stored in a bank is to
be directed for later personal or family use, because most conditions that might be helped
by cord blood stem cells already exist in the infant's cord blood (i.e., premalignant
changes in stem cells). Another way to explain this to parents is the potential for children
needing their own stored cord blood stem cells in the future for autologous (self) use is
controversial at this time (Johnson, 1997). There is also not any evidence of the safety or
effectiveness of autologous cord blood stem cell transplant for the treatment of malignant
neoplasms. There is evidence demonstrating the presence of DNA mutations in cord
blood obtained from children who eventually develop leukemia (Rowly, 1998).
Therefore, autologous cord blood transplantation might even be contraindicated in the
treatment of a child who develops leukemia. Care providers should be aware of the
unsubstantial claims of private cord blood banks made to future parents that promise to
"insure" infants or family members against serious illnesses in the future by use of the
stem cells contained in cord blood. Although not standard of care, directed cord blood
banking should be encouraged when there is knowledge of a full sibling in the family
with a medical condition (malignant or genetic) that could potentially benefit from cord
blood transplantation.
Cord blood donation should be encouraged when the cord blood is stored in a
bank for public use. Parents should be informed that chromosomal abnormalities and
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infectious disease testing is performed on the cord blood and that if abnormalities are
identified, they notified. Parents need to know the cord blood banked in a public program
may not be accessible for future private use.
Private storage of cord blood as "biological insurance" should be discouraged.
Cord blood banks should comply with national accreditation standards developed by the
Foundation for the Accreditation of Cellular Therapy (FACT), the US Food and Drug
Administration (FDA), the Federal Trade Commission, and similar state agencies.
The following recommendations are suggested to minimize any barriers to parents
through institutions or organizations (private or public) involved with cord blood
banking:
Cord blood banking recruitment practices should be developed with an awareness
of the possible emotional vulnerability of pregnant women, their families and friends.
Efforts should be made to minimize the effect of this vulnerability on cord blood banking
decisions such as discussions with providers well in advance of active labor.
Accurate information about the potential benefits and limitations of allogeneic
and autologous cord blood banking and transplantation should be provided. Parents need
to be informed that autologous cord blood would not be used as a stem cell source if the
donor developed leukemia later in life. Parents need to know that cord blood is a tissue
source not proven to be used as yet in regenerative medical purposes but the advancement
of the science is continuing at this time.
Policy should be developed by the cord blood banks regarding disclosing to the
parents any abnormalfindingin the harvested blood.
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Specific permission for maintaining demographic medical information should be
obtained, and the potential risks of breaches of confidentiality should be disclosed.
Written consent should be obtained before onset of active labor.
If blood bank is conducting research, an institutional review board must review
and approve recruitment strategies and consent forms.
Cord blood collection should not be performed in complicated deliveries. The
cord blood stem cell collection program should not alter routine practice for the timing of
umbilical cord clamping.
All cord blood banking programs should comply with FACT or equivalent
accreditation standards.
Other professionals and physicians who recruit pregnant women and their families
for for-profit placental cord blood stem cell banking should disclose anyfinancialinterest
or other potential conflict of interest they have in the procedure to their patients.
Professionals affiliated with institutions or organizations that promote for-profit
placental blood stem cell banking should make annualfinancial-disclosureand potentialconflicts-of-interest statements to an appropriate institutional review committee that
possesses oversight authority.
Targeted efforts should be made to recruit underserved minorities (black,
Hispanic, American Indian/Alaska Native individuals) in public cord blood banking
programs to extend to them potential treatments afforded other segments of society.
Conclusion
This was a mixed method of quantitative and a small qualitative research piece.
The qualitative method was limited due tofinanciallimitations and time limitations.

Thirty of the surveys were entered into this research for analysis with one third of them,
eleven, sharing an additional interview with the researcher centered on the question of
cord blood donation. Two additional participants were not used as they changed their
decision to participate. The respondents had a poor overall understanding of cord blood
banking. There were multiple barriers to accurate information between public and private
banking. Even though the majority of the respondents were Hispanic with a high school
education and some even had completed two years of college, a respondent who had a
doctorate degree in philosophy also had a difficult understanding between public and
private cord blood banking and difficulty locating where to access a public cord blood
bank. Part of the puzzle is also accessing banks that have proper funding because
allocation of funding to public banks is limited. The aim of the survey was to conduct it
with most of the respondents in the 22 to 24th week of pregnancy but some were
conducted later in the pregnancy at approximately 32 to 36th week of pregnancy. It is
unlikely that more women would have made a decision regarding cord blood storage if
they had been surveyed later in pregnancy because the Cord Blood Collection (CBC)
Survey and the Stages of Readiness Scale for Decision Making reflected the knowledge
they had during their pregnancy at the time. Moreover, despite the high proportion of
women in this survey who were in the stages of readiness, they desired to leam more and
did want to donate cord blood. Many in this marginalized population did not have an
opportunity to donate cord blood as they were not able to afford thefinancialburden of
the cost through private cord blood donation. Along with this, there was not a local public
cord blood bank in the geographic area of San Diego during the time of this study 20092011.
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Future research should focus on strategies to educate women earlier in the
pregnancy or during the pre-conceptual period so they are prepared to make a truly
informed decision at the appropriate time. The researcher was still amazed in an
industrialized country such as the United States how easy one can organize their choices
in life to donate organs for end of life on their driver's license, which they are required to
carry on their person, enter options for possible transplant donation before ones demise,
and even arranging for breast milk banking and donation without too many barriers but
the steps to take to complete a contribution to a public cord blood bank seems to continue
to be a barrier throughout this advanced technology. One may see the change coming
slowly but only from the consumer driven based decision to request public cord blood
banking from their healthcare provider, their healthcare provider learning how to
contribute through the process of public cord blood collection, and seeking the avenues
for public donation can this option possibly advance to make this less cumbersome for
the public at large. The future of stem cell research will depend on this and advance the
technology of cord blood use in treating multiple diseases.
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STEM CELL SOURCES

I

ADVANTAGES
• Non-controversial and supported by
legislation
• More cells may be available per
collection
• Mows for future collections
• Demonstrates some degree of
developmental plasticity (ability to
be molded)
• Indicated as therapy for numerous
human diseases and used in
transplant for more than 40 years

•

•
•

1
•

•

•
•
•

1
•

•

•

Non-controversial, readily
available, and supported by
legislation
Highly proliferative and improves
the rate of self-renewal
Increased developmental plasticity,
allowing differentiation into
multiple cell types
Tolerant of 2 or more HLA
mismatches duetoimmunologic
immaturity
Indicated as therapy for numerous
human diseases (75) and used in
transplant for more than 15 years
Decreased rates of GVHD (graft
vs. host disease)
Young cells with longer telomeres
Highly proliferative improving the
rate of self-renewal
Increased developmental plasticity,
enabling differentiation into
multiple cell types
Involved in research that furthers
our understanding of cellular
development
Young cells with longer telomeres

DISADVANTAGES
• Less proliferative than younger cell
types
• Tolerant of only 1 or fewer HLA
antigen mismatches
• Provides older cells with shorter
telemeres
• Invasive collection procedure that
poses some risktothe donor
• Registries are subjecttodonor
attrition
• Increased rate of GVHD (graft vs.
host disease) compared with use of
younger cells
• One-time collection, at birth only
• Cell count limitedtoquantity
available at birth, until expansion
technologies are approved for use in
patients
• Delay engraftment when samples
with decreased cell dose are used

•
•
•

(Young, 2006)

Controversial and heavily restricted,
even for research purposes
No validation in human patients
Difficult to regulate and prone to
teratoma formation (tumors)
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Diseases potentially treatable with umbilical cord blood stem cell transplants
Acute leukemias
Acute biphenotypic leukemia
Acute lymphoblastic leukemia
Acute myelogenous leukemia
Acute undifferentiated leukemia

Lymphoproliferative
disorders
Hodgkitfs disease
Non-Hodgkin's lymphoma
Prolymphocyte leukemia

Chronic leukemias

Phagocyte disorders
Chronic lymphocytic leukemia Chediak-Higashi syndrome
Chronic myetogenous leukemia
Chronic granulomatous
Juvenile chronic myelogenous
disease
leukemia
Neutrophil actin deficiency
Juvenile n^omonocytic
Reticular dysgenesis
leukemia

Myelodysplastic syndromes
Chronic myeiomonocytic
leukemia
Refractory anemia
Refectory anemia with excess
blasts
Refectory anemia with ringed
sideroblasts

Liposomal storage
diseases

Histiocytic disorders
Familial erytfaropbagocytic
lyrriphohistiocytosis
Hemophagoeytosis
H&iocytosis-X

Inherited erythrocyte
abnormalities
Beta thalassemia major
Pure redceD aplasia
Sickle cell disease

Congenital (inherited) Immune
system disorders

Adiendeukodvstrophy
AbsenceofT& BCeflsSCfD
Gauchers disease
AbserceofTCells^NormalBCell
SOD
Hunter's syndrome
Ataxia-telangiectasia
Hurler's syndrome
Bare lymphocyte syndrome
Krabbe disease
Maroteaux-Lamy syndrome Common variable immunodeficiency
Metachromatic
DiGeorge syndrome
leukodystrophy
Kostmann syndrome
Leukocyte adhesion deficiency
Morquio's syndrome
Omenris syndrome
Mucolipidosis II (I-ceH
disease)
SCID with adenosine deaminase
Mucopdysaocharktoses
deficiency
NiernanrtPiek disease
Severe combined immunodefiaency
Sanffippo's syndrome
disease(SCID)
Scheie's syndrome
Wiskott-Aldrich syndrome
Sly syndrome, 13X-linked Lymphoprolflerative disorder
glucuronidase deficiency
Wolman disease
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Stem cell disorders
Fanconi's anemia
Paroxysmal nocturnal
hemoglobinuria

Other malignancies
Breast cancer
Ewing sarcoma
Neuroblastoma

Other inherited disorders
Cartflagehair hypoplasia
Gianzmann's thrombasthenia
Lesch-Nyhan syndrome

Severe aplastic anemia

Renal cell carcinoma

Osteopetrosis

Myeloproliferative
disorders
Aoite myofibrosis
Agnpgenic myeMmetaplasia
Essential thrombocytbemia
Polycythemia vera

Platelet abnormalities
Amegakaryocytosis
Congenital thrombocytopenia

Plasma cell disorders
Multiple myeloma
Plasma cell leukemia
WakJenstrorris macroglobulinemia

SCID = severe combined immunodeficiency disease
(Adapted from Moise, 2005; Perlow, 2002)
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Appendix C
Stages of Change Model

stable behaviour

contemplation I

relapse

pre-contemplation.

Stages of Change Model

Figure 1: Stages of Change Model
Prochaska, J.O. & DiClemente, C.C. (1982). Transtheoretical therapytowarda more integrative
model of change. Psychotherapy: Theory, Research and Practice, 19 (3), 276-287,
(Prochaska & DiClemente, 1982).
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Table 1: Asian UBC Inventory of Use and UCB Transplants (August 2004)
Cord blood
bank

Inventory

Transplanted

Children

Adult

Beijing

5,800

44

26

70

Tianjin

5,400

15

10

5

Seoul

32,000

84

80

4

Taipei

6,700

9

9

-

Ho Chi Minh

1,076

7

7

-

Bangkok

315

1

1

-

Tokyo

5,563

277

105

172

Total

56,854

437

238

197

(Agarwal, 2006)
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Table 2: Regenerative Medicme Activities in Low- and Middle-Income Countries

Country

Dedicated
government
Funding

Brazil

*

Goods and
services

Companies

Publications

Academic
institutions
*

*

China

*

*

India

*

*

*

*

*

*

*
*

Argentina

*

Bulgaria

*

*

*

Chile

*

*

*

Malaysia

*

Mexico

*

Poland

*

*

*

*

*

*

*

*

*

Slovakia

*

*

*

*

South
Africa

*

*

*

*

Thailand

*

*

*

*

Columbia

*

*

*

Cuba

*

*

*

Egypt

*

*

*

*

*

Russia

*

Belarus
Hungary

*

Iran
Latvia

A

*
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Lithuania

ft

-

*

Pakistan

ft
ft

Romania
Saudi
Arabia

ft

Serbia

*

Turkey

ft

ft

Ukraine

*

ft

ft

Vietnam

ft

Moldova

ft

Philippines

ft

Uganda

ft

(Greenwood, 2006)
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Milestones in Umbilical Cord Blood Banking and Transplantation
Year

Event
Discussions between H. Broxmeyer and T.
Boyse about the potential clinical use of
UCB as a source of hemotopoietic stem
cells.
E. Gluckman and colleagues in Paris
perform first related donor UCB transplant
for a child with Fanconi anemia.

1982

1988

1989

R. Harris and colleagues in Cincinnati,
Ohio, perform the first related donor UCB
transplant in the US.

1993

J. Kurtzberg and colleagues at Duke
University in Durham, North Carolina,
perform the first unrelated donor UCB
transplant.
P. Rubenstein and colleagues at the New
York Blood Center establish the first
public, unrelated donor cord blood bank.
J. Wagner and colleagues report in The
Lancet the results of related and unrelated
donor UCB transplants.
The National Heart, Lung and Blood
Institute of the National Institutes of Health
award funding for UCB banks and
transplant centers to conduct a national
safety and efficacy trial.
J. Kurtzberg and colleagues report in the
New England Journal of Medicine the first
large series of unrelated donor UCB
transplants.
P. Rubenstein and colleagues report in the
New England Journal of Medicine results
from 562 unrelated donor UCB transplants
performed worldwide.
Cryo-cell and Gen-cell first initiation to
collect placentas for placental stem cell
research by Gen-cell and Cryo-cell.

1993

1995

1996

1996

1998

2006

UCB = Umbilical cord blood
(Smith, 2000; Cryo-cell, 2006)
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BANKING: Private versus Public Banking in the United States and Europe
• Private donation is predominate; it's often called Family Banking as it may be given
to a related member of that child.
• Recruitment from OB clinics, via the Internet & promotional material
• Inducements-incentives to recruiters with commission on every "sale"
• Parents in form of club membershipforthe child which gives entrytoa
sweepstakes providing accesstofour$10,000 college scholarships/yr
• Federal government supported by NIH grants, charitable foundations, Am. Red Cross,
(Gunning, 2006)
UNITED STATES
Private or Family

Public

Initial Fee

$1,100to$1,975
Includes cost of kit

Storage

$115to$225/year

Process if needed

No fee

Free Processing fee $1,000
which the bank incurs
$l,000/unit
May charge the insurance
company
Can be $15,000-$35,000/unit
May charge the insurance
company

• Public donation is predominate; parents donate their child's cord blood for
unrelated use.
• Recruit from OB clinics but within a local or regional network; difficult to donate if they
do not come from within the geographic area of public banking
• Ensure wide diversity of ethnic groups
• Sources of funding-Red Cross, Jose Cameras Foundation, charitable foundations as
ADISCO (Italy), Commonwealth state and territory government research and
community funding, (Gunning, 2006)
EUROPE
Private

Public

Initial Fee

€175 ($150)
Includes cost of kit and cost
of initial processing

Free

Storage

€175 ($150)
Includes cost of kit and cost
of initial processing

Free

Processing if needed

No fee

Charge ifhave insurance
Otherwise no charge
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Appendix H
Staging Algorithm for Cord Blood Donation Intention with
Readiness of Change Model

Table 1: Staging Algorithm for Cord Blood Donation Intention and Spouse
Notification
Cord Blood Donation
Intention

Stage
Precontemplation

Contemplation

Preparation

Action

Maintenance

Spouse Notification

I have not given any
thought to discussing with
my spouse how I feel about
cord blood donation.
I'm giving some though to I'm giving some thought to
being a cord blood donor discussing with my spouse
and weighing the pros and how I feel about cord blood
cons.
donation.
I'm preparing to be a cord I'm preparing to talk with
blood donor, learning more my spouse about how I feel
about cord blood donation.
about consent options.
I have signed a cord blood
I have talked with my
consent, but I have not yet
spouse about how I feel
talked with my spouse
about cord blood donation.
about this.
I have talked with my
I have signed a cord blood
spouse about how I feel
consent, and I have talked about cord blood donation,
with my spouse about this.
and about how he feels
about cord blood donation.
I have not given any
thought to being a cord
blood donor.

AdaptedfromProchaska et al. (Prochaska, Velicer, & Rossi, 1994; Quinn, Alexander,
Hollingsworth, O'Connor, & Meltzer, 1994)

127

Appendix I
Fox Questionnaire
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Table 1. Demographic characteristics of study participants
Overall %

Donating to
Private bank %

Age

<20
20-29
30-39
>40
NA

Gestational Age

<24 weeks
24-35 weeks
>36 weeks
NA

Number of
Children

0
1
2
>2
NA

Marital Status

Married
Single
NA

Race

American Indian/ Alaskan Native
Asian/ Pacific Islander
Black
Hispanic
White
Other
NA

Religion

Buddhist
Christian
Hindu
Jewish
Muslim
No religion
Other
NA

Donating to
Public bank %

Highest level
of education
completed

lst-8ai grade
9th-12* grade
Undergraduate college
University degree
Postgraduate degree
NA

Economic
status

less than $50,000/year
$50,000-$ 100,000/year
greater than $100,001 up to $150,000/year
greater than $150,001 up to $200,000/year
greater than $200,001 up to $250,000/year
greater than $250,001 up to $300,000/year
greater than $300,001 up to $400,000/year
greater than $400,001 up to $500,000/year
greater than $500,001/year

Method of
payment for
prenatal care

Self-pay
Insurance
NA

Table 2. Patients' sources of knowledge about cord blood donation
Yes/No

DonatetoPrivate Bank %

DonatetoPublic Bank %

Discussed cord blood collection with obstetrician.
If did not discuss with obstetrician, plan on discussing cord blood collection with obstetrician.
Seen/read kterature distributed by private/commercial cord blood collection companies regarding
cord blood storage.
Seen/read ads in magazines/commercials regarding cord blood storage. Seen/read literature
distributed by a public cord blood bank regarding cord blood donation.

Table 3. Patients' beliefs about cord blood collection, storage and use.
Overall %

DonatetoPrivate Bank %

Donate to Public Bank %

Would it make a difference in a decisiontostore cord blood with a private/commercial cord blood
bank if you knew that your obstetrician would be paid a feetocollect the cord blood?
Yes
No
N/A
The chance that my baby would have a condition (at birth or in the future) that could benefit from
cord blood during his/her first 10 years of life is about:
1 in 100
1 in 1000
1 in 10,000
<1 in 10,000
N/A

131

The chance that a sibling who is now healthy would develop a condition that could benefit from
this cord blood is about:
1 in 100
1 in 1000
1 in 10,000
<1 in 10,000
N/A
For most conditions requiring cord blood therapy, could a child use cord blood from
his/her own placenta?
Always
Usually
Sometimes
Rarely Never
N/A
For most conditions requiring cord blood therapy, could a child use cord bloodfroma
sibling's placenta?
Always
Usually
Sometimes
Rarely
Never
N/A
If your child did need cord blood therapy and you did not have cord blood storedfromhim/her
or a sibling, what is the chance cord bloodfroma public storage bank could be used?
Always
Usually
Sometimes
Rarely
Never
N/A
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Table 4 Patients' knowledge about current incfieatiomfOTCoribloodtansr^
Overall %
Donate to Private Bank %
Donate to Public Bank %
Does SanDiegohosptalslmveasysiemin place whereby ywcoukidcnatethecoidblood to a public cord
blood bank?
Yes
No
Dorftknow
N/A
Forthe fbltowirigconditions,rAaseindtbatew
as a therapy:
Alzheimer's disease
Yes
No
Dorftknow
N/A
Asthma
Yes
No
Dorftknow
N/A
Blood cancer (such as leukemia or lymphoma)
Yes
No
Dorftknow
N/A
Certain genetic diseases ofthe immune system (such as'Bubble Boy1'disease)
Yes
No
Dorftknow
N/A
Certain inherited diseases of metabolism (like "Lorenzo's Oil" disease)
Yes
No
Dorftknow
N/A
Diabetes
Yes
No
Dorftknow
N/A
Failure of the bone marrow
Yes
No
Don't know
N/A
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Parkinson's disease
Yes
No
Dont know
N/A
Red blood cell or hemoglobin disorders (such as sickle cell disease)
Yes
No
Don't know
N/A
Spinal cord injury
Yes
No
Don't know
N/A
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Appendix J
Sources of Knowledge, Beliefs, Knowledge on Transplants to Stages of Readiness Scale
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Table 5. Sources of Knowledge, Beliefs, Knowledge on Transplants to
Stages of Readiness Scale
Questions from Precontemplation
3
Questionnaires
Patients'
sources of
knowledge
about cord
blood donation
Patients'
beliefs about
cord blood
collection,
storage and
use.
Patients'
knowledge
about current
indications for
cord blood
transplantation.

Contemplation Preparation Action Maintenance
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Appendix K
Interview Guidelines

Interview Guideline: Cord Blood Donation
1.

How did you hear or see information about cord blood donation?

2.

When did you receive information about cord blood donation?

3.

Tell me what your understanding ofthe process in cord blood donation is and how it occurs?

4.

Have you discussed cord blood donation with your obstetrician, PCP, or CNM yet? Do
you plan to do so?

5.

Would it make a difference in a decisiontostore cord blood with rmvate/commercial cord
blood bank if you knew that your obstetrician, PCP, or CNM would be paid a fee to
collect the cord blood?

6.

What is your understanding regarding a chance that your baby would have a condition (at
birth or in the future) that could benefit from cord blood during his first 10 years of life?

7.

Ifyou chosetostore cord blood in a private/commercial bank what would be your primary
reason?

8.

If you chose to store cord blood in a public bank what would be your primary reason?

9.

Tell me how you feel about San Diego hospitals having a system in place whereby you
could donate cord bloodtoa public cord blood bank at the birth of your child?

10. Do you have anyfnoughts about your future beliefs regarding stem cell research through
cord blood collection?
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Appendix L
Consent
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Cord Blood Donation Information and Assent Form
Irene Carr, RN, MSN CFNP, CNM, doctoral candidate and student, University of San
Diego is mterviewing volunteers as part of herresearchstudy. The purpose of the study:
•

To develop better understanding ofpublic and private cord blood
donation, storage and use.

•

To obtain community members perspectives on the option ofcord blood
donation in the San Diego County.

•

To obtain input from a broad segment of the population

Participants, couples and individuals, interested in the phenomenon of how they are making
decisionstocollect cord blood at the birth of their child and what is their understanding and belief
about this process will be addressed in a questionnaire followed by an interview. Those willing to
express their views on stem cellresearchfromcord blood collection and how they make a decision
to use private or public banking will be addressed. You will be asked other characteristics
relevant to the study.
The interview will involve one interview that asks questions about your pregnancy and how
you heard about cord blood collection. The interview will last about 60-90 minutes and also will
include some questions about you, such as your age, gender, gestational age, number ofchildren you
have birfhed,rac^ethnicity,religion,highest level of education completed, financial status, and
method of payment for prenatal care. The interview will take place at a time and place convenient
for you. Participation is entirely voluntary and you can refusetoanswer any question and/or quit at any
time. Should you choose to quit, no one will be upset with you and your information will be

destroyed right away.
The information you give will be analyzed in a manner that protects your identity. That means
that a code number will be used and that your real name will not appear on any of the materials
used
There may be a risk that participating in the interview may make you feel tired. Remember,
you can stop the interview at anytimeyou feeltiredor for any other reason The otherriskmay be
discourse in your decision to donate or not donate cord blood.
The benefit to participating will be in knowing you helped doctoral nursing students
leam how to ensure every pregnant woman the opportunity to make a well informed
decision about cord blood donation/banking.
If you have any questions about this interview, please contact Dr. Mary-Rose Mueller at
the University of San Diego, 619-260-4562.

I have read and understand thisform,and agreetothereseaixfopurposes it describes to me.
This form is given to me for my records.

Signature of Participant

Date of Interview
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Appendix M
Recruitment Flyer

BANK
CORD BLOOD at Birth
SURVEY
DECISION to DONATE

Amanda Louise Enisley

Nurse researcher is actively seeking women during their
pregnancy to volunteer for a survey regarding their
knowledge on cord blood banking. Takes 15 minutes.
Please contact Irene Carr, MSN, FNP-BC, CNM at
619-823-5650 OR 619-262-5925 for further information.
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Appendix N
Bureau of Labor Statistics
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Appendix O
Answers to Interview Questions
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Interview Questions on Cord Blood Donation
How did you hear or see information about blood donation?
1. TV commercial and internet.
2. TV and @ UCSD. "1 had to make a choice between circumcision and
donating cord blood."
3. My PCP asked me.
4. TV
5. My doctor.
6. Television and OB, PCP.
7. From my doctors office.
8. Dr Irene Carr.
9. From my midwife.
10. OB family Nurse Practitioner... she gave her handout.
11. Information by mail & information from doctor in the office information
display.
When did you receive information about cord blood donation?
1. Not applicable.
2. Papers w/last pregnancy 5 yrs ago.
3. Today!!
4. I have not information.
5. I don't know.
6. During early pregnancy.
7. Second trimester.
8. Today, 5/06/2010.
9. Today, 5/17/2010.
10. At 12 weeks gestation.
11. Continuously
Tell me what your understanding of the process in cord blood donation is and how it
occurs?
1. You give consent for hospital or Party to take donation.
2. Some hospitals have kits kept there if you decide to use them. UCSD has kits.
I did not get kits.
3. I would like to do this.
4. I don't have a lot of understanding because I really don't know much about it.
5. I don't know.
6. Hospital collects it, sends it to bank; if baby has leukemia in future you can
use the blood from the bank.
7. I don't know.
8. "No answer"
9. I need more information regarding Cord Blood Donation to decide what my
future choices.
10. Private versus Public.
11. Not very much.
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Have you discussed cord blood donation with your obstetrician, PCP, CNM yet? Do you
plan to do so?
1. YES.
2. Yes, as sickle cell is in my family members.
3. Yes.
4. No, haven't discussed it with my obstetrician. Maybe.
5. 1 have not. I don't know.
6. Yes.
7. No, But I plan to do so.
8. 1 need to talk with my husband.
9. I do not know much about it at this time.
10. Yes.
11. No. But maybe I am ready now. (this participant is 39 weeks GA).
Would it make a difference in a decision to store cord blood with private/commercial
cord blood bank if you knew that your obstetrician, PCP, CNM would be paid a fee to
cotlect the cord blood?
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.

Yes.
No.
Don't know.
Don't know.
Yes.
Yes.
NO.
"No Answer."
Yes, it depends.
No difference.
NO!

What is your understanding regarding a chance that your baby would have a condition (at
birth or in the future) that could benefit from cord blood during his first 10 years of life?
1.
Little or no understanding.
2.
Yes in the next ten years sickle cell may surface in my kids.
3.
Don't know.
4.
Don't know.
5.
I don't know. I do not have any children yet.
6.
I understand it can be used if your child has leukemia.
7.
Pretty good understanding.
8.
"No answer."
9.
"No answer."
10.
No idea of rates and condition.
11.
I do not know what the probabilities are???
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If you chose to store cord blood in a private/commercial bank what would be your
primary reason?
1.
It would be beneficial and free to do so.
2.
For the health of my kids.
3.
Don't know.
4.
To benefit my child.
5.
In case it is ever needed for my child.
6.
For the health of my baby.
7.
For private/family use.
8.
For the future if my daughter would need it.
9.
Is it a safe procedure?
10.
Just to have it available, if one needs it.
11.
To help my son if he had a disease.
If you chose to store cord blood in a public bank what would be your primary reason?
1.
It would be free to do so, and it would be available to my child if needed,
as well as others.
2.
It's free. Everyone can use it. Many don't have money to pay for private
donation.
3.
Don't know.
4.
To benefit my child.
5.
In case it is ever needed.
6.
For the health of my baby.
7.
They do not offer this in San Diego.
8.
Some babies may need this.
9.
Is it a safe procedure.
10.
The low cost.
11.
I am not sure what the difference between storing privately and publically.
Tell me how you feel about San Diego hospitals having a system in place whereby you
could donate cord blood to a public cord blood bank at the birth of your child?
1.
I think it would be a great ideal if it were free for personal and public use.
Yet, 1 would be against it if it was to profit financially to companies or
misused.
2.
Yes that would be great but they don't have one right now.
3.
I think it's good.
4.
Don't know.
5.
I'm neutral about it.
6.
Good it can help anyone because you don't know at the time of the
birth.
7.
No thoughts.
8.
"No answer."
9.
If it is a safe procedure I would not mind.
10.
I would use it if it was available.
11.
That would be great if this was available.
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Do you have any thoughts about your future beliefs regarding stem cell research through
cord blood collection?
1. I like the idea of stem cell research to help people and cure diseases—Yet, I
do not approve of companies profiting off of donated cord blood or misuse or
sale of such discoveries.
2. They should do it.
3. No.
4. No.
5. No, I do not.
6. Yes, continue to do the research and educate parents on their options.
7. I think it is a great idea.
8. "No answer."
9. I will look into it and research about it.
10.1 am learning; and I am still learning.
11. It seems like a good idea if it is cost effective and safe.

